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Diabetic foot ulcers (DFU) are one of the most challenging complications associated with 
diabetes mellitus (DM).  Every 1 in 4 patients with DM are expected to develop an ulcer 
in their life time. The time course of healing is on average 90 to 120 days which increases 
the risks of infection, amputations and death. Nitric oxide (NO) is a signaling molecule 
produced in the body that has been established in the literature to serve many roles in the 
body, including as a vasodilator, neurotransmitter immune modulator and antimicrobial 
agent. Emerging evidence has shown that NO is indispensable in every stage of wound 
healing and its dysregulation is a major hinderance in the healing of DFU. The problem 
associated with harnessing the biological effects of NO is that it is very reactive and 
consequently it is extremely difficult to measure. As a result, majority of the studies in the 
literature measure its metabolic products (nitrate and nitrite) to correlate NO function. The 
challenge with relying on NO metabolites is that they can only be analyzed at static time 
points as an accumulation measure and they do not give any information about the dynamic 
NO changes taking place in the wound environment. Moreover, the NO dose produced by 
specific cells during the course of cell migration and proliferation varies depending on the 
stage of wound healing. The function of NO is very complex with its effects ranging from 
protective to deleterious depending on the dose and duration of the treatment and even the 
surrounding host environment. It is therefore of paramount importance to understand the 
real-time NO profile produced and exposed to the cells that are actively involved in the 
wound healing process and to analyze how the profile changes in physiological and 
pathological conditions. This dissertation presents the real-time NO levels produced from 
normal and chronic wound fibroblast cells cultured in normal and high glucose conditions 
when stimulated by inflammatory mediators that are commonly present in the wound 
environment. The results showed that the real-time NO levels produced by fibroblasts are 
higher in normal glucose compared to high glucose cell culture conditions (8.42±1.16 vs 
3.26±0.79 nmols/105 cells). The real-time NO levels were significantly increased in normal 
glucose with stimulation compared to normal glucose without stimulation. High glucose 
conditions in the absence and presence of stimulation showed no statistical difference 
between the two groups. The NO levels produced by fibroblasts obtained from biopsy 
samples from patients treated at a chronic wound care clinic was suppressed. Overall there 
was no statistical difference within the experimental groups. The NO levels produced by 
the cells did not correlate with the nitrite and nitrate detected in the fluid obtained from the 
wound site (nanomolar vs micromolar concentration respectively). The results were 
compared with the well characterized macrophage cell line RAW 264.7 which also showed 
higher NO levels (161.80± 29.05 vs 46.30±12.9 nmols/106 cells) in normal glucose 
compared to high glucose conditions and no statistical difference in the nitrite levels in 
normal and high glucose conditions. The results clearly indicate the need for real-time NO 
monitoring to determine the level and duration of NO production by cells in the wound bed 
and that the use of nitrite and nitrate does not provide accurate information regarding NO 
dysregulation in chronic non-healing wounds. The work presented herein will facilitate the 
development of treatments that address not only the actual dose of NO treatment needed in 




Diabetes mellitus (DM) is by far the most prevalent and one of the most challenging 
non communicable disease[1] currently dealt in the world. In 2000, the estimated 
number of people living with DM worldwide was 151 million with costs of treatment 
greater than $44 billion in the United States alone [1]. The population affected was 
predicted to go up to 300 million in 2025[2]. However, as of 2017, the global 
prevalence of diabetes has already risen to 425 million with increased healthcare costs 
of US$ 727 billion. Currently, it is predicted to affect 629 million people by 2045[3]. 
DM encompasses a group of metabolic conditions that result in high glucose levels (> 
7Mm) [4]. It exists in 4 main categories; DM type 1, DM type 2 , gestational DM and 
genetic defects in the beta cell function DM[5]. The most predominant being type 1 
and type 2 DM. DM Type 1 is mainly an autoimmune disease of the younger population 
that causes destruction of pancreatic beta cells and reduced production of insulin that 
is necessary for glucose metabolism[6]. A common finding in patients is the presence 
of the histocompatibility antigen HLA-DR3/DR4. Other risk factors include; 
environmental exposures, gender differences, ethnicity, infections, seasonal variation 
and location[2]. DM Type 2 is characterized by the inability to maintain fuel hemostasis 
due to hyperglycemia and altered lipid metabolism. There is no destruction of the islet 
cells. However, there is inadequate insulin production and negative body responses 
resulting from over nutrition, obesity and inactivity[7]. In contrast, it mainly affects the 
older population although the risk factors remain similar to type 1 DM.  More recently  
it has become more prevalent among the younger population especially in North 
America (10-14 years) [8]. In almost all DM patients, the high circulating blood glucose 
levels (hyperglycemia) causes a multi organ effect that can lead to complications on a 
micro (neuropathy, retinopathy and nephropathy) and macro vascular scale (coronary 
artery disease, stroke and peripheral vascular disease). The prevalence and mechanisms 
of each of these complications can be found elsewhere[9-13]. This dissertation focuses 
on peripheral vascular disease with emphasis on diabetic foot ulcers (DFU).  
It is reported that every 1 in 4 people living with DM will develop a foot ulcer. In the 
US, 1 million cases of diabetic foot ulcer complications were recorded in various 
emergency departments from 2006-2010. The costs of treatment for both in care and 
out care patients in 2014 surpassed 10 billion dollars[14]. Unfortunately, the clinical 
outcomes of DFU are very grim. The main reason is the prolonged healing time which 
on average is about 90-120 days [15]. This increases the risk of infection resulting in 
sepsis, amputation and death [16]. (Figure 1-1). Additionally, these non-healing 














Figure 1-1 The prevalence and clinical outcomes of DFU 
 
1.1 The physiological wound healing process and alterations in 
DFU  
Wound healing proceeds in 4 complex and overlapping stages; hemostasis, 
inflammation, proliferation and remodeling [18-21](Figure 1-2). The duration can vary 
depending on the injury, age, genetic makeup and co morbidities of the individual[21]. 
However, in majority of cases, it is approximately 3 weeks[22].  
During the first 24 hours following injury, platelets are released at the wound site, and 
in the presence of a number of extrinsic and intrinsic factors, a fibrin plug is formed 
preventing blood loss and infection. The fibrin plug provides a provisional matrix 
scaffold for the migration of immune cells[22]. The platelets also release growth factors 
such as platelet derived growth factor (PDGF), insulin like growth factor (IGF), 
epidermal growth factor (EGF) and transforming growth factor-Beta (TGF-ẞ) that are 
essential for recruiting inflammatory cells at the wound site[23]. 
The arrival of immune cells, marks the beginning of the acute inflammatory phase, 
which peaks at 24 hours and lasts 3-4 days[24]. The capillaries dilate and become more 
permeable through mediation by prostaglandins (PG) specifically; PGI2, PGD2 and 
PGE2. Vasodilation will slow down the blood flow in the post capillary venules 
allowing transmigration to take place. Circulating neutrophils align on the basement 
membrane, selectins P and E are upregulated on the endothelial cells that line the blood 
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vessels, which makes it possible for the neutrophils to slow down and cross the 
basement membrane into the affected tissue space. Other neutrophil chemotactic agents 
such as; leukotriene B4 (LTB4), complement component 5a (C5a), Tumor necrotic 
factor-alpha (TNF-α), TGF-ẞ, platelet factor 4 (PF4), interleukin1 (IL1), interleukine 
8 (IL8), and bacterial products further facilitate neutrophil recruitment at the wound 
site[24, 25]. Neutrophils produce hypochlorous acid (HClO)  through the 
myeloperoxidase pathway to sterilize the wound[26]. In addition, neutrophils cleanse 
the wound of necrotic debris by forming a phagolysosome. To modulate the acute 
immune response, platelets will adhere to neutrophils and through the 5-lipoxygenase 
pathway, the association will lead to the formation of  lipoxins A4 and B4 that act as a 
checkpoint to stop the infiltration of neutrophils.[26, 27]Circulating blood monocytes 
will migrate to the wound and differentiate into macrophage cells. Macrophages co-
ordinate host defense, immune response and  direct the wound healing process  by 
taking on two opposite polarized forms, both of which can be lethal if overly expressed; 
M1 (kill function) and M2 (heal function)[28, 29]. The granulocyte macrophage and 
macrophage colony stimulating factors (GM-CSF and M-CSF) are key players that 
initiate macrophage polarization into classically (M1) and alternatively (M2)  activated 
macrophages respectively [29, 30]. In the next 2-3 days following hemostasis, the 
predominant phenotype is M1. The function of M1 is enhanced in the presence of 
inflammatory mediators’ interferon-Ƴ (IFN-Ƴ), TNF-α and bacterial products 
lipopolysaccharide (LPS). M1 produce large amounts of superoxide and express the 
inducible nitric oxide synthase enzyme (iNOS), which generate nitric oxide (NO) from 
the conversion of the amino acid L-arginine into L- citrulline [31, 32].NO and 
superoxide are responsible for the antimicrobial properties of M1 and will be discussed 
later in this project. Other roles of M1 include clearing the wound bed of necrotic tissue 
and microbial products by phagocytosis[33].M1 also recruit Th1 cells which are 
involved in the adoptive immune response. TH1 are responsible for the destruction of 
intracellular parasites and produce high levels of the proinflammatory cytokine IFN-
Ƴ[34]. When the wound is sterile, macrophages switch to M2 that counteract the pro-
inflammatory effects of M1 cells through activation of Th2 cells[33]. Th2 secrete the 
anti-inflammatory cytokines IL-4, 5, IL-10 and IL-13[34]. M2 are further activated by 
IL-4 produced by TH2 cells, eosinophils and basophils. Glucocorticoids secreted from 
the adrenal gland also activate M2 cells[33]. Interestingly, M2 also utilize the amino 
acid arginine to produce ornithine via the enzyme arginase-1. Ornithine promotes cell 
growth, collagen production and tissue repair[29, 30]. In a rat model, M2 macrophages 
appeared on day 7 of healing in healthy rats, and it also marked the beginning of the 
proliferation stage of wound healing[35]. Growth factors PDGF and EGF produced by 
both macrophages and platelets attract the migration and proliferation of fibroblast cells 
from the wound edge[25].  Fibroblast cells deposit extracellular matrix (ECM) that is 
indispensable for re-epithelialization and tissue remodeling to take place. The initial 
components of the matrix produced are collagen type 3, glycosaminoglycans (GAGs), 
specifically chondroitin sulphate, tenascin and fibronectin [36, 37]. Fibronectin 
promotes adhesion of the cells to the fibrin scaffold deposited by the platelets[37]. The 
hydration capacity of chondroitin sulphate increases the mechanical strength and serves 
as a temporary matrix during the first two weeks of healing[36].  Tenascin regulates 
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the cell shape and therefore function of the cell. In addition, tenascin plays a role in 
maintaining the tissue hemostasis [36, 38]. Ploeger et al[39] demonstrated that like 
macrophages, fibroblasts also exhibit an element of plasticity depending on the 
polarized form of macrophages. In this study, human dermal fibroblasts cultured in M1 
conditioned media upregulated inflammatory cytokines in fibroblasts and increased 
their ability to degrade the ECM while fibroblasts cultured in M2 conditioned media 
had the inverse effect. This strongly suggests that in the early phases of wound healing, 
a more compliant matrix is necessary to allow the free movement of cells to their 
destinations as well as sprouting of vessels to ensure adequate nutrition for the growth, 
maintenance and function of the cells. Matrix metalloprotease enzymes (MMPS) 
secreted by macrophages, fibroblasts (collagenases, gelatinases, stromelysin) and 
plasmin present in the serum are responsible for the breakdown of the ECM[40]. In 
addition, MMPS modulate the inflammatory response through the degradation and 
activation of chemokines[41]. The activity of MMPS is in turn also regulated by tissue 
inhibitors of matrix metalloprotease enzymes (TIMPS) produced from fibroblasts that 
are stimulated by TGF-ẞ and IL-6. Studies also show that fibroblast cells produce low 
levels of NO [42-44]. However, the specific role of the NO produced still needs to be 
determined.  
The proliferation and migration of fibroblasts initiates the granulation/remodeling 
stage. The former flexible matrix is gradually replaced by a stiffer and more permanent 
scaffold. This is the most important phase of the healing process because it determines 
the risk of recurrent injury depending on the matrix that is deposited. Several factors 
are involved and the concentration of each one needs to be precisely controlled to 
facilitate the formation of an appropriately organized and mechanically sound tissue. 
The benefit is to maintain isometric tension which prevents the shortening and 
lengthening of cells during the remodeling process. The switch from M1 to M2 
macrophages promotes the production of ECM by fibroblasts. TGF-ẞ produced from 
M2 stimulates the production of collagen type 1 [25, 45].  The permanent matrix that 
is formed is composed mainly of type 1 (80-90%) which increases the wound breaking 
strength. Moreover, TGF-ẞ  mediates the transformation of fibroblasts into 
myofibroblasts that are responsible for wound contracture[46]. Other formed elements 
of the ECM include elastin which adds resilience and elasticity to the wound. In 
addition, the cleavage of elastin by MMPS releases tropoelastin that helps in the 
attachment, spreading and proliferation of fibroblasts[47].  The granulation/remodeling 
stage can last about a year and the scar that is formed will only achieve 80% strength 
of the uninjured skin tissue under physiological wound healing conditions[25].   
A key feature in wound healing is epithelialization. This is the process of covering a 
denuded epithelial surface and  is critical to achieve wound closure [48] 
Epithelialization starts as early as day 4 during wound healing. The cytokines IL-1 and 
TNF-α stimulate fibroblasts to produce keratinocyte growth factors (KGF) 1, 2 and IL-
6 which attract the keratinocyte cells at the wound edge[25]. Epithelialization is a layer 
by layer process that requires keratinocyte cells to detach from the basal layer, migrate 
and proliferate across the newly formed matrix of the wound bed to allow a sufficient 
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cell density to close off the wound[49] (Figure 1-2). The degradation of the ECM by 
MMPs releases and activates growth factors that promote proliferation of keratinocyte 
cells. These growth factors include: EGF, TGF-α, KGF and heparin-binding EGF-like 
growth factor[50]. The keratinocytes also promote angiogenesis by secreting vascular 
endothelial growth factor (VEGF) and IL4. When the migrating/proliferating 
keratinocytes from both ends of the wound meet, they cease to proliferate (contact 
inhibition)[51]. In addition, growth factors like TGF-ẞ synthesized by the fibroblast 
cells, stop the proliferation of keratinocytes by causing a switch from activated to basal 
keratinocyte phenotypes [49, 52].  Thereafter, cornification begins in the supra basal 
layer. Cornification is an elegant form of cell death. It proceeds with keratinocyte cells 
switching to a terminally differentiating phenotype accompanied by the synthesis of 
cornified envelope  structural proteins and lipids that are covalently bonded by specific 
transglutaminases to form a spinous, granular and desquamous layer that acts as a 
barrier against the hostile external environment [52].  Epithelialization usually lasts 
approximately 2 weeks [53].  
 
        Figure 1-2. The physiology of wound healing 
The successful closure of a wound involves an intricately coordinated cross talk 
between immune cells and resident cells such as the keratinocyte and fibroblasts that 
allows temporal and spatial control over the production and function of the different 
elements required for the formation of healthy tissue.  The harmony of this wound 
environment relies greatly on metabolic, chemical, and mechanical cues that are 
significantly altered in DFU that leads to impaired healing. 
The diabetic foot is a metabolic disorder characterized by a pathological triad; 
neuropathy ischemia, and infection that results in the development of a chronic 
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ulcer[54], which is a breakdown in the skin that extends from the surface to the 
subcutaneous tissue, muscle and bone[55]. It is termed chronic when it does not heal 
in an orderly or timely manner and does not result in structural integrity[56].  
In the mitochondria, hyperglycemia causes an abnormally high membrane potential. 
Above the threshold, electron transport at complex III of the electron transport chain is 
inhibited with an increase in the half-life of the co- enzyme Q that reduces oxygen to 
superoxide. Superoxide inhibits the glycolytic enzyme glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) causing an increase in the glucose flux and enhancement of 
the polyol pathway[57]. The result is the consumption of NADPH that is needed for 
the regeneration of antioxidant molecules such as glutathione. In the absence of 
antioxidants, there is an accumulation of reactive oxygen and nitrogen species (ROS 
and RNS) which activate the master transcription factor of inflammation, nuclear factor 
kappa beta (NF-kβ) [58, 59]. NF-kβ influences gene expression and the production of 
number of chemokines namely IL-1, IL-6 and TNF-α [60]. The latter proteins lead to 
insulin resistance further aggravating hyperglycemia[61]. The increase in oxidative 
stress induces nerve damage, impairs vascular reflexes, peripheral vasodilation and 
bone resorption.  All these factors augment the likelihood of a bone fracture and foot 
deformity consequently increasing the risk of foot trauma. Moreover, the loss of 
sensation that accompanies neuropathy also increases susceptibility to injury for the 
patient. Glucose binds to residue amino groups on polypeptides and lipids to form 
advanced glycation end products (AGEs)[62].  AGEs bind to the receptor of advanced 
glycation end products (RAGE) on endothelial cells, vascular smooth muscle cells and 
macrophages, which in turn also activate NF-kβ[61, 63].  Glycation of the structural 
proteins collagen and laminin found in the basement membrane of the blood vessels 
impairs the electric charge and leads to increased membrane permeability and stiffening 
of the vessel wall[64]. The effect is most pronounced in the microcirculation where it 
leads to an increase in hydrostatic pressure and shear forces resulting in the injury of 
the endothelium lining. There is a release of extravascular matrix proteins that leads to 
basement membrane thickening[65]. In the event of a foot injury, the thickened vessel 
makes it difficult for immune cells to migrate to the affected area and also increases the 
risk of infection that hinders the healing of the ulcer. Neuropathy also reduces the 
formation of neuropeptide proteins (nerve growth factor, calcitonin, substance p that 
are involved in recruiting cells to the wound site[66]. Poor cell infiltration is 
accompanied by a deficiency in growth factors and molecules that are required for the 
ideal symphony of events that lead to wound regression.  
Advanced treatments have been developed that take advantage of the different factors 
(Mechanical, chemical and biological cues) involved in the physiological wound 
healing process. These include; Silver impregnated dressing (Aquacel Ag®) which 
effectively cleanses the wound of infection while absorbing excess exudate and 
maintaining a moist environment ideal for wound healing[67]. Medihoney® gel 
dressing that acts as debridement agent and lowers the pH at the wound site[68]. 
Polyurethane foam (Allevyn®) facilitates gaseous exchange and absorbs excess 
exudate which facilitates the healing process[69]. Hydrogels also provide a moist 
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environment ideal for healing and lowers the temperature at the wound site[69]. Other 
dressings incorporate collagen and growth factors (PDGF and EGF)[70, 71] 
consequently providing a suitable milieu for the formation of granulation tissue.  
Unfortunately, none of these dressing have resulted in an adequate response or healing 
time for diabetic foot ulcers[72].  
 
1.2 The role of NO in wound healing and its alterations in DFU  
Nitric oxide is a gaseous molecule that was first characterized by Joseph Priestly in 1772 
and before 1980 was viewed mainly as an air pollutant present in automobile exhaust and 
cigarette smoke. However, as a result of the work done by Robert Furchgott, Louis Ignarro, 
Marek Radomski and Ferid Murad, it is now well known in the literature for its myriad of 
roles in maintaining vascular homeostasis, inhibition of inflammation and bacterial 
invasion, facilitating wound healing and as an intercellular signaling molecule involved in 
neurotransmission [73-76]. In the body, NO is primarily produced via a metabolic pathway 
involving L-arginine, Ca2+/calmodulin, oxygen, nicotinamide adenine dinucleotide 
phosphate (NADPH), tetrahydrobiopterin (BH4) and one of three nitric oxide synthase 
(NOS) isoform enzymes depending on the tissue and cell type. The NOS enzyme aids in 
the transfer of electrons from NADPH in its carboxyl terminal reductase domain to the 
heme in the amino-terminal oxygenase domain. This domain binds oxygen and BH4. The 
heme reduces oxygen and oxidizes L-arginine into L-citrulline and NO. Calmodulin is 
required to facilitate the flow of electrons (Figure 1-3).  All the isoforms can bind 
calmodulin at different affinities depending on the intracellular calcium levels and binding 
site structure on the enzyme. There are 3 NOS isoforms that have been identified so far. 
NOS -1 (neuronal) and NOS-3(endothelial) are constitutively expressed in the cells of 
origin and  require increased calcium concentration to bind calmodulin (200-400 nM) while 
NOS-2 (inducible) expression is induced by inflammatory mediators and is referred to as 




Figure 1-3. The metabolic pathway of NO generation 
In 1992, Heck et al reported the first production of NO in the skin by keratinocyte cells 
when stimulated by inflammatory mediators[79]. The cells expressed NOS confirmed by 
an enzyme activity assay. The maximal activity required both ca and calmodulin showing 
probable dependence on constitutively expressed NOS isoforms. The production of NO 
was observed to regulate the proliferation of keratinocyte cells. It was later confirmed that 
keratinocytes constitutively express NOS-1 and can be induced to express NOS-2 as 
well[80-82]. Since then, there have been several studies reporting NO production in the 
skin when exposed to various stimulating factors as well as expression of the different NOS 
isoforms in cells that are actively involved in the wound healing process (Table 1.1 ). 
During hemostasis, NO produced from endothelial cells activates the enzyme guanylate 
cyclase which initiates the cyclic c-GMP pathway to inhibit platelet aggregation and 
enhance vasodilation. Endothelial cells express NOS-3 responsible for NO production.  In 
the inflammatory phase, M1 produce significant amounts of NO (>0.5mM) that acts to 
destroy microbes and prevent infection of the wound.  In fact, the highest NOS activity 
occurs in the early phases of wound healing [31] and is predominantly produced from 
macrophages. The NO levels are drastically reduced (0.01-0.25mM) when the wound 
transitions to the proliferation stage [80, 83-85]. M1 convert to M2 macrophage cells that 
do not produce NO. However, fibroblast cells produce low levels of  NO (nanomolar range) 
and express both NOS-1 and NOS-3 isoform enzymes[42, 43]. The low concentrations of 
NO have a more anti-inflammatory effect on wound healing.  A prime example is the 
inhibitory effect on NF-κβ signaling. NO acts directly through S-nitrosylation of the p50 
subunit of NF-κβ and inhibits its binding to DNA[86]. The NO produced in fibroblasts has 
been shown to regulate collagen production[44]. It is also speculated that these low NO 
levels produced from fibroblasts act as the first response before the immune cells arrive at 
the wound site [43, 80]. The NO role in the proliferation of fibroblasts has not been well 
established and its impact on their migration still needs to be determined. Low NO levels 
also play a role in extracellular matrix remodeling/turnover. Ridnour et al demonstrated the 
effect of NO treatment on modulating the activities of MMPS-1,9 and 13[87]. NO promotes 
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angiogenesis through the activation of the growth factors VEGF, TGF and bFGF [88]. In 
keratinocytes, the production of VEGF is controlled by NO production [89]. In addition, 
NO has been shown to exert antiapoptotic effects through regulating the activity of  
antiapoptotic markers such as HIF-1α [90] and inhibition of caspase activity [91].  It is 
therefore conceivable that the doses of NO produced at the wound site change gradually 
over the time course of healing to ensure that the production and regulation of growth 
factors proceeds as expected to maintain the phenotype and the function of the cells at each 











NO is highly reactive and very short lived and this dictates its overall effect on the cells. 
In the presence of aggravating factors, there are mechanisms in place to maximize the 
biological effect of NO in order to produce an appropriate host response. The most 
important is the maintenance of nitroso-redox balance. If the stimulus persists or in case of 
inadequate feedback, it alters the equilibrium of the wound environment, which is the 
hallmark of dysregulated healing in DFU.  




Figure 1-4. The predicted nitric oxide levels produced from cells in the 
different stages of wound healing 
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1.2.1 Nitroso-redox balance in the pathophysiology of diabetic foot ulcers 
Redox balance is determined by the change in the oxidative state of an atom[96]. An 
addition of electrons results in reduction and a loss in electrons leads to oxidation[97]. An 
imbalance between these two states causes oxidative stress that has deleterious effects on 
the healing process. Reactive oxygen and nitrogen species (ROS and RNS) as well as 
antioxidants are the major players in maintaining redox balance. Examples of ROS and 
RNS include; superoxide (O.), hydrogen peroxide (H2O2), hydroxyl radical, hypochlorous 
acid (HClO), nitric oxide (NO), and peroxynitrite (ONOO.).   
1.2.1.1 Sources of ROS and RNS  
Hydrogen peroxide formation 
The spontaneous transfer of an electron to superoxide at low pH or by an enzyme reaction 
(superoxide dismutase) produces hydrogen peroxide (H2O2)[98, 99]. H2O2  readily diffuses 
across intra and intercellular membranes where it is involved in either cell signal 
transduction or cytotoxic effects [99]. Hydrogen peroxide is a potent antimicrobial agent 
at high concentrations (500 µM)[100]. In the inflammatory phase, H2O2 augments the 
phosphorylating capacity of the enzyme tyrosine kinase which downstream amplifies the 
signal at the antigen receptor site of the cell[101].  













































Hydroxyl radical formation 
The hydroxyl radical (.OH) can be formed from the reaction of H2O2 with superoxide 
(Haber weiss reaction) or via the breakdown of H2O2  by metal ions; Fe2+ or Cu2+( Fenton 
reaction) [102]. .OH is highly reactive, it interacts with DNA, lipids, proteins and 
carbohydrates causing severe cell damage [103].  Although, a study has shown a dose 
dependent effect of .OH on fibroblast function. The authors used an ascorbate-copper ion 
system to generate hydroxyl radicals.  Low levels (<10mumol/l) increased collagen 
polymerization and high levels (>100mumol/l) evoked degradation of collagen showing a 
possible role of .OH in remodeling of the ECM[104]. 
Hypochlorous acid formation 
Hypochlorous acid is mainly produced by leuckocyte cells from the reaction of H2O2 with 
chloride anions that originate from the uptake of extracellular fluid by the cell[105]. The 
reaction is catalyzed by the enzyme myeloperoxidase (MPO) [24, 105]. HClO has very 
strong antimicrobial effects and facilitates the removal of foreign particles and damaged 
tissue. However, because of its cytotoxic effects it also affects the surrounding host 
environment.  
 
NO and peroxynitrite 
Nitric oxide readily diffuses rapidly in water and lipids which makes its functions very 
diverse. Its effects can be direct and indirect depending on the redox state. NO reacts with 
metal ions such as ferrous heme to form a nitrosyl-heme complex. This mechanism is used 
to activate the enzyme guanylate cyclase consequently  converting  GTP to cGMP which 
downstream dictates majority of NO function especially in hemostasis[106]. NO also reacts 
with the thiol groups in proteins through covalent post translational modification of 
proteins[92] (s-nitrosylation). An example is the NO effect on transglutaminases by s-
nitrosylation of the cysteine residues on their protein structure. Transglutaminases facilitate 
the cross linking of the proteins in the ECM during epithelialization, proliferation and 
remodeling[107]. The rate constant of both mechanisms is approximately 105-106 M -1 S -1.   
In the presence of ROS specifically superoxide, indirect effects of NO manifest because it 
rapidly reacts with superoxide at a rate that is faster than its reactions with proteins/metal 
ions (1.9 x 1010 M-1 S -1 ) or the reaction of superoxide with the scavenger superoxide 
dismutase (SOD) (2 X 10 9 M -1 S -1) [92] to form the more reactive and toxic compound 
peroxynitrite[108] [58, 96]. At low concentrations, peroxynitrite acts as a signaling 
molecule through activation of 3 tyrosine phosphorylation and the mitogen activated 
protein kinases (MAPK) pathway which activates glycolysis and controls cell proliferation 
respectively [58, 96] . In one study, it was shown to have antiapoptotic effects by inhibiting 
caspase-3 activity through s nitrosylation in adhesion fibroblasts.[109].  Unfortunately, the 
majority of peroxynitrite effects are cytotoxic. It modifies protein molecules by reacting 
with the amino acids tyrosine and tryptophan to form nitrotyrosine and nitrotryptophan 
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respectively.  It also nitrates lipids and nucleic acids resulting in DNA damage. The damage 
to DNA structure over activates the enzyme poly (ADP-ribose) polymerase-1 (PARP-1) 
which consumes NAD+, ATP and eventually leads to cell dysfunction and death. At 
physiological pH, peroxynitrite decomposes into more toxic species; nitrogendioxide and 
hydroxyl radical [92]. 
1.2.1.2 Antioxidant mechanisms  
To maximize the biological functions and reduce the accumulation and deleterious effects 
of ROS and RNS, the body produces a variety of antioxidants. The toxic effects of  
superoxide are controlled  through dismutation by antioxidant enzymes SOD[58, 97]. 
Under physiological conditions, H2O2 levels are controlled through inactivation by the 
enzyme glutathione peroxidase in the presence of the amino acid glutathione or the enzyme 
catalase which convert H2O2 into oxygen and water [97]. Evidence shows that NO its self-
acts as a substrate for MPO through the reaction with its end product NO2-  which reduces 
and inactivates the MPO compound 1[110]. Whether this could be a mechanism for 
regulating HClO still needs to be investigated. Peroxynitrite accumulation can be 
controlled by glutathione peroxidase in the presence of  glutathione (GSH) which regulates 
its cytotoxic effects[111]. Studies have shown an aggravated effect of hypovolemic shock 
in case of increased toxicity by peroxynitrite and low GSH levels[112]. At high doses, NO 
can also be toxic. In vivo, the detoxification of NO is achieved mainly through its reaction 
with hemoglobin. [58, 113]. NO also reacts rapidly with oxygen to form nontoxic 
compounds nitrate/nitrite[114]. SOD also regulates NO and the production of peroxynitrite 
by scavenging superoxide[115]. 
1.2.1.3 Oxidative and nitrosative stress in diabetic foot ulcers  
In the diabetic state, persistent hyperglycemia leads to an over production of superoxide by 
activating different pathways; polyol pathway, xanthine and NADPH oxidases, 
cyclooxygenases, uncoupled nitric oxide synthase, glucose auto-oxidation, mitochondrial 
respiratory chain[57]. The result is high ROS levels and low antioxidants, a state defined 
as oxidative stress. The high levels of superoxide surpasses the body’s antioxidant 
mechanisms. Superoxide activates the NF-κβ transcription factor which upregulates 
expression of NOS-2 and consequently NO production.   In the presence of high superoxide 
and low levels of the super oxide scavenger molecules, NO will react very rapidly with 
superoxide to produce peroxynitrite consequently reducing the bioavailability of NO. 
Moreover, high ROS and peroxynitrite levels in the hyperglycemic state limits the 
production of BH4 (an indispensable co factor for NO production) and causes the 
uncoupling of NOS to generate superoxide instead of NO [96, 116, 117]. The concentration 
of arginase is another mechanism that interferes with NOS activity. Arginase competes 
with NOS enzymes for the substrate arginine and reduces NO availability favoring 
superoxide production. A diabetic induced state was found to increase arginase activity 
levels in the wounds of diabetic mice and this correlated to delayed healing observed in the 
study [35]. The deficiency of NO alters endothelial vascular function causing vessel 
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constriction. Moreover, in diabetic patients with high cholesterol levels, the presence of 
peroxynitrite favors lipid peroxidation and induces an inflammatory response, activating 
platelet aggregation[96]. These effects are mostly pronounced in the small blood vessels 
and plays a role in the progression of neuropathy[118].  Vascular impairment can result in 
persistent ischemia. Wounds are often associated with low oxygen tension[119]. In 
physiological conditions cells express HIF-1 α, a key transcription factor that allows the 
cells to adopt to hypoxic conditions. HIF-1α promotes angiogenesis, cell proliferation, cell 
survival and energy metabolism. NO is a key regulator in the expression of HIF-1α. The 
effect of NO on regulation of HIF-1 α is very complex and yet indispensable to cell survival 
and function under external insult. It is reported that the effect of NO on HIF-1 α is 
primarily mediated by S-nitrosylation.[120]. In normoxia (1-10mmHg) and hypoxia, high 
levels of NO (> 1µM) stabilize the HIF-1 α transcription factor while low NO levels (<400 
nM) in hypoxia destabilize it[121]. During the early phases of wound healing when M1 are 
predominant, it is possible that the high NO production from the cells facilitate the 
stabilization of the protein in order to produce an adequate adoptive response to injury and 
when this is resolved the low NO levels produced from the other cells promote resolution 
in the wound environment to restore its normal state. In fact, Pena and O’Neil[122] report 
a possible link of HIF-1α protein in the polarization of macrophages which might be 
regulated by NO concentration. The association of ischemia in the presence of 
hyperglycemia has devastating effects on the redox and metabolic state in the wound bed 
by altering NO function and consequently adoptive response to the hypoxic environment.   
Catrina et al showed that HIF-1 α protein levels were low in human endothelial and dermal 
fibroblast cells cultured simultaneously in hyperglycemic and hypoxic conditions[123]. In 
the same study, biopsy samples obtained from patients with DFU showed lower HIF-1 α 
staining in the nucleus and cytoplasm compared to non-diabetic patients with chronic 
wounds. Jazayeri et al [124] also showed increased expression of proapoptotic marker p53 
as well as ischemia induced apoptosis in diabetic mice and dermal fibroblasts cultured in 
hyperglycemic conditions. It is interesting that NO in a dose dependent manner also 
regulates both HIF-1 and p53 expression. Thomas et al[90] showed that a single high 
dose of NO (>2000 nM) increased the P53 P-Ser-15 protein levels while the same dose 
delivered over a longer period of time increased HIF-1α protein levels instead.  A 
contrasting study showed inhibition of HIF-1  accumulation by NO in liver and cancer 
cells (50 µM). However, addition of peroxynitrite scavengers alleviated this effect [125]. 
Patients with diabetes have been found to have high levels of nitrotyrosine in plasma[126]. 
Another study showed increased peroxynitrite production in diabetic platelets [115] and 
other researchers have found high levels of nitrotyrosine levels in rat and mice diabetic 
skin which correlated to the dysregulation in the wound healing process[127, 128].  
The number of factors that affect wound healing are intertwined and very diverse. It is 
further complicated in an altered metabolic and redox environment where the absence or 
malfunction of one factor affects a cascade of events downstream. This is clearly 
demonstrated in the key signaling molecule NO. The complexity of NO makes its 
interpretation in vivo and invitro studies very sensitive to concentration, duration of NO 
delivery and redox environment. These are all very important factors to consider in terms 
of the response and efficiency to a given treatment plan for DFU. 
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1.3 Current methods used to measure NO in diabetic conditions 
and their limitations  
The high reactivity and very short half-life of NO makes it extremely difficult to measure 
directly under physiologically relevant conditions. As a result, the majority of studies in 
the literature rely on its metabolic decomposition products nitrite/nitrate, enzyme activity 
assays and protein levels. However, because of the complex chemistry of NO in an altered 
cell or tissue environment, it is very difficult to interpret results from different studies and 
draw a conclusion on the actual role of NO in a given pathology. In addition, the 
decomposition of its toxic species such as peroxynitrite can also generate nitrite/nitrate in 
vivo and invitro[112, 129]. It is therefore not surprising that NO studies in diabetic states 
show contradicting results in the levels of NO determined as well as the outcome based on 
these methods of analysis (Table 1-2).  
 
Table 1-2. Experiments and analysis methods and outcomes on the effect of NO in 
diabetic states  
SAMPLE SPECIES NO 
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In a diabetic mouse model, Miao et al found that M1 cells were deficient at the wound site 
by staining for iNOS/cd68 macrophage marker. These cells mainly appeared early on in 
the wound healing process and the levels of iNOS staining cells was low in diabetic mice 
compared to controls. The low levels of iNOS were correlated to low NO levels and 
delayed wound healing. The upregulation of the iNOS enzyme shows a causal relationship 
with NO however it does not always translate to the actual levels of NO produced or how 
it relates to cell function. For example, the islet cells in the pancreas stained positive for 
nitrotyrosine an indicator of peroxynitrite destruction in another diabetic mouse model. 
The formation of this protein was decreased in the presence of iNOS inhibitors or 
superoxide scavengers[140]. In another study, high glucose increased NOS-3 expression 
in vascular endothelial cells, although nitrite levels measured in the media was low. When 
the superoxide scavenger SOD was added, nitrite levels were restored[131].  Another 
indicator of this inconsistency is in Hwang’s study, the researchers looked at the effect of 
high glucose on NO production in macrophage cells. The results showed that macrophages 
produced more NO compared to cells cultured in normal glucose conditions and the NO 
was reduced when an anti-inflammatory compound glucosamine was added[132]. The 
nitrite accumulation in the media was taken as an indicator of NO production. In addition 
to NO, macrophages also release significant amounts of superoxide which would greatly 
have an effect on the bioavailability of NO released.   
The majority of NO treatments in physiological cell culture conditions have shown a 
positive effect on the function of cells involved in wound healing. For example, the NO 
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donors sodium nitroprusside, Diethylenetriamine NONOate (DETANO) and S-nitroso-N-
acetylpenicillamine (SNAP) in a dose dependent manner  improved migration in 
keratinocyte cells [141]. In other study, the migration and re-epithelialization  of epidermal 
stem cells was accelerated in the presence of NO donor SNAP[142]. Similarly, normal and 
diabetic wound animal models have shown success which supports the theory that NO 
levels are low in diabetic conditions and when integrated back into the system, these NO 
levels are restored. (Table 1-3).  
 





However, the translation of NO treatments in patients affected with DFU has yielded 
insufficient results despite the fact that most of these clinical trials were completed (Table 
1-4).  
MODEL  SPECIES/CELL 
TYPE 
TREATMENT         EFFECT REFERENCES 
Cell culture  Keratinocytes  SNP/DETANO/
SNAP, GSNO  
Improved cell migration 
and proliferation  
[141, 143] 








Cell culture  Epidermal stem 
cells  
SNAP Improved cell migration 




















and granulation tissue 
[144, 148] 
S-Nitrosoglutathione (GSNO), polycaprolactone (PCL), chitosan-based NO-releasing biomaterials 
 (CS-NO) 
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Table 1-4  Reports on clinical trials that applied NO treatments to patients with DFU  
 
 
This shows the problem of relying only on biproducts or enzyme activity to dictate NO 
function. The assumption in the Griess assay is that all the NO produced is converted to 
nitrite in the presence of an enzyme nitrate reductase. This method is not quantitatively 
accurate and is susceptible to variations depending on the media or buffer used[151]. The 
sensitivity of the assay is also quite low with a detection limit of approximately (0.1-
0.5µM). With NOS activity, it is inferred that the presence of the NOS enzyme represents 
NO levels and function which is also grossly inaccurate since the enzyme can uncouple to 
STUDY  REGISTR
ATION # 
STATUS         OUTCOME REFERENCES 
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generate other reactive oxygen species [116].  Most importantly, they are all accumulation 
assays and the means of determining the rate of production of NO or how this rate changes 
over time in different pathological states is practically impossible. He and Frost[152] 
developed a novel measurement   system (the CellNO trap) that allows the direct, real-time, 
continuous measurement of NO produced or exposed to cells under conventional culturing 
conditions using chemiluminescence, one of the most sensitive and specific methods for 
detecting NO through its reaction with ozone[74]. This device has previously been 
validated and used to characterize the rate and amount of NO produced in macrophage cells 
as well as the actual levels of NO that cells are exposed to when treated with soluble NO 
donors[153]. The authors proved that the average or maximum NO measured is not an 
indicator of the dynamic character of NO. In addition, they showed how adding of different 
NO mediators commonly used in the literature affects the NO release in real-time. For 
example, adding arginine, the NO substrate that is frequently used to increase NO 
production in various studies had different effects on the NO release profile in stimulated 
macrophage cells depending on the time that it was added. The results from the same study 
also showed that the Griess assay recorded significantly lower NO levels compared to the 
real-time NO measured. He and Frost [153] further demonstrated that various conditions 
such as the pH, CO2, reaction volume and redox environment affect the ultimate NO levels 
that cells in culture are exposed to. The soluble NO donor DETANO at different pH levels 
in the presence and absence of CO2 showed different NO release profiles. At physiological 
pH, there was an increase in NO release which stayed constant for 24 hours. In the presence 
of CO2, there was higher peak of NO which gradually reduced over 24 hours and at pH 6 
the NO level had the highest peak but by 15 hours the NO treatment was depleted [153]. 
In a study, that included 50 patients with chronic and acute wounds, the baseline pH levels 
of most wounds was approximately 8.5[154]. The evidence that the NO release from NO 
donors alters with changes in pH further proves that without the knowledge of the dynamic 
changes in the NO released from NO donors, the outcome of these treatments is 
unpredictable.  Moreover, the soluble NO donor SNAP showed large variation in its NO 
release profile for different replicates measured[153].  Three studies (Table 1-3) showed 
that both SNAP and DETANO accelerated migration, improved proliferation and re 
epithelialization of keratinocytes, epidermal stem cells and fibroblasts in invitro wound 
healing models. However, the NO release kinetics of these two NO donors were not 
determined. The authors relied only on the overall analytical concentration of the NO 
donors which might prove to be a challenge in reproducing these effects in NO treatments 
for DFU. On the bright side, two clinical studies have shown promising results.  In patients 
with diabetic neuropathy, isosorbide dinitrate alleviated pain but did not show an effect in 
improving other sensory symptoms[155]. The use of this organic nitrate compound has 
been very successful in patients with heart failure when administered with an 
antioxidant[156] which might equally show better results for diabetic patients with 
peripheral vascular disease if the same mode of administration is employed.  The second 
study was in a randomized clinical trial in which patients were given an NO release wound 
dressing sustained for 12 weeks. There was significant reduction in wound area, improved 
healing and minimal adverse effects compared to patients treated with standard wound 
dressings. The study was also superior to others because they included patients with 
ischemic and infected ulcers. While it showed a positive response in wound healing,  the 
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absolute effects of NO could not be measured and the NO levels at the wound site of the 
patients was also  unknown[149]  [157]. 
1.4  Statement of purpose  
Brüne and Zhou used an interesting analogy to define the role of NO and hypoxia. They 
described this relationship as one ranging from courting to matrimony and divorce[121]. 
In essence this same analogy can be used to describe the overall NO function in the 
physiological wound healing process and its alteration in DFU. Wound healing is very 
dynamic and complex with different yet overlapping stages that are controlled from the 
molecular to the cellular and tissue level. It’s clear that NO is needed in each of these 
stages. However, the timing, dose and duration of NO produced is very distinct and its 
function at a given time relies greatly on the redox environment. This harmony is severely 
altered in an unstable metabolic state like diabetes and consequently it plays a major role 
in the improper and delayed healing of DFU. Therefore, understanding how the direct NO 
levels produced from the cells actively involved in healing changes over time in both 
physiological and pathological conditions is extremely critical in developing NO 
treatments to reestablish skin integrity. The work herein mainly focuses on using the device 
that was previously developed to determine the real- time NO levels produced from cells 
involved in wound healing under physiological and diabetic conditions. Chapter 2 shows 
the real- time NO produced from normal human skin fibroblasts cultured in normal glucose 
conditions and how the levels of NO change in high glucose conditions in the presence and 
absence of inflammatory mediators. This study reports the first ever assessment of real- 
time NO produced from human dermal fibroblast cells. Chapter 3 adopts these culture 
conditions to determine the real- time NO produced in human wound dermal fibroblast 
cells isolated from a patient with a chronic ulcer. In addition, a highly sensitive method of 
analysis is validated to determine the nitrite and nitrate levels present in wound fluid 
obtained from patients with chronic ulcers. Chapter 4 reports the changes in NO levels 
produced from the macrophage cell line RAW 264.7 cultured in normal and high glucose 
conditions and finally chapter 5 looks at the potential applications of real-time NO 
measurements in localized NO delivery systems and in the determination of the role of NO 
in the progress of cardiovascular calcification. 
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2 INVESTIGATIVE STUDY OF REAL-TIME NO 
MEASUREMENTS IN NORMAL FIBROBLAST CELLS 
IN NORMAL AND HIGH GLUCOSE CONDITIONS1  
Fibroblasts are the most prevalent cell type in the dermis layer of the skin. The main 
function of fibroblasts is to secrete the extracellular matrix (ECM) scaffold, for all cells 
residing in the skin tissue [158]. They are the most important mesenchymal cells and are 
defined as the architects of the wound healing process. The main component of the ECM 
is collagen which replaces the fibrin provisional matrix. Other elements include 
proteoglycans, glycoaminoglycans (GAGS), heparin sulfate and elastin that facilitate the 
aggregation of collagen fibrils, direct cells, cytokines and growth factors within the ECM 
as well as providing flexibility to the skin [159]. Fibroblasts also regulate the growth and 
function of other cells involved in wound healing through the production of growth factors 
and secretion of MMPS. Table 2-1 shows the components produced by fibroblasts and 
their roles during healing. A few studies have emerged that provide evidence of NO 
production from fibroblast cells. Wang et al showed that human skin fibroblasts produced 
low levels of NO and express both constitutive and inducible forms of NOS[43]. The NO 
produced was hypothesized to be involved in the inflammatory process before the arrival 
of the immune cells. In a follow up study that consisted of cells isolated from hypertrophic 
burn tissue and site marked normal skin tissue, NO levels, enzyme activity and expression 
were reduced in cells isolated from hypertrophic scar tissue compared to normal skin tissue.  
The authors drew the conclusion that NO helps to control the proliferation of cells and its 
deficiency was evidence to explain hypertrophic scar formation in patients. During the 
same period, Schaffer et al also showed NO production from mouse wound dermal 
fibroblasts played a role in collagen deposition and wound mechanical strength. In the same 
study, the group demonstrated that wound fibroblast cells produce NO while normal 
fibroblasts do not produce NO. Furthermore, the NO levels were reduced in subsequent 
cell passages. Other authors have reported increased NO production from human skin 
fibroblasts when irradiated with UV light and showing potential  in regulating  the 
proliferation of the cells[160]. The NO production in fibroblasts is altered in diabetes. In 
Schaffer et al’s study,[161]  the wound breaking strength and collagen deposition was low 
in wounded diabetic induced mice compared to normal mice and this correlated with the 
low nitrite levels in the wound fluid and cells isolated from these wounds. Another group 
of researchers showed that the NO production was low in fibroblast cells cultured in 
diabetic conditions and it was significantly increased when the cells were irradiated with a 
light source. Moreover, cell migration and proliferation in diabetic conditions was 
improved when the cells were irradiated with light[162]. It’s interesting that none of these 
studies looked at the direct NO levels or how the production of NO would change or alter 
the effect observed depending on the culture conditions. The researchers only looked at 
                                                 
1 The majority of the work presented in this chapter was submitted and published in Medical Sciences and 
the rights to use this content is presented in appendix C and licensed under Creative Commons Attribution 
4.0 International License 
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nitrite or enzyme activity to correlate the function and production of NO in fibroblast cells 
which might not be an accurate assessment. 
 
Table 2-1 Elements produced by fibroblasts and their function in wound healing  
 
 
In this chapter, we specifically elucidated the temporal aspects (both rate and amount) of 
NO produced by human dermal fibroblasts under normal glucose (5.5mM) and high 
glucose (25mM) conditions. For the first time, we report the actual levels of NO that human 
dermal fibroblast cells produced in real-time both with and without stimulation. The rate 
of cell proliferation and the expression of the iNOS enzyme responsible for the production 
of NO when the cells are stimulated by inflammatory cytokines was also assessed.  The 
real- time NO and nitrite accumulation were measured in the cells and cell culture media, 
Elements Function         References  
Collagen, proteoglycans, hyaluronic 
acid, tropoelastin and elastin  
 
Strength, cell movement, 
aggregation of collagen 
fibrils, direct and regulate 
function of cells and growth 
factors, resilience and 
elasticity  
 
[26, 158, 163] 
Cytokines (IL-1, IFN-γ, TNF-α) 
 
Stimulate production of 
growth factors, regulate 
inflammatory response   
[26, 163] 








Growth factors                             (NGF, 
TGF-β, PDGF, FGF.EGF) 
Nerve growth, keratinocyte 
proliferation, angiogenesis, 
cell proliferation, chemotaxis 
 
[26, 163, 168] 
MMPS and TIMPS ECM remodeling, activation 




respectively, and compared. By understanding the levels of NO produced and how it 
compares to the nitrite and the protein expression in these cells under both normal and 
diabetic conditions, we will begin to clearly understand the levels and timing of NO 
delivery necessary to promote appropriate fibroblast proliferation, migration and 
deposition of the extracellular matrix in order to reduce the healing time in chronic DFUs. 
2.1 Materials and Methods  
2.1.1 Cell culture and chemical supplies  
Primary human adult dermal fibroblasts (HDFa, ATCC® PCS-201-012™,), mouse 
macrophages (RAW 264.7), penicillin streptomycin, fetal bovine serum (FBS), phosphate 
buffered saline (PBS), MTT proliferation assay kit and Dulbecco’s modified eagle medium 
(DMEM high glucose 4500mg/l) were all purchased from ATCC (Manassas, VA). DMEM 
(no glucose), sodium pyruvate and Hoescht dye were obtained from Fischersci (Hanover 
Park, IL). D-(+)-Glucose, Lipopolysaccharide pseudomonas aeroguinosa (LPS), Calcein-
AM, protease inhibitor cocktail, mouse nitric oxide synthase and dopamine-HCl were 
purchased from Sigma-Aldrich (St. Louis, MO). Ethidium bromide was acquired from 
Invitrogen (Grand Island, NY). Human recombinant Interferon gamma (hrIFN-Ƴ) was 
purchased from GenScript (Piscataway, NJ). The primary and secondary antibodies against 
CD90/Thy1 (ab23894) protein and inducible nitric oxide synthase (iNOS) (ab136918) 
were purchased from Abcam (Cambridge, MA). The 7.5% SDS polyacrylamide gels and 
gelatin were acquired from Bio-Rad (Hercules, CA). The Odyssey western blot starter kit 
2 was obtained from LI-COR (Lincoln, NE). Silicone elastomer base and curing agent 
(Dow Corning Sylgard®184) were obtained from ML Solar LLC (Campbell, California).  
 
2.1.2  Real time NO measurements from Primary human adult dermal 
fibroblasts 
Primary adult dermal fibroblasts at passage 1 were cultured and expanded in conventional 
cell culture plates (100mm) in DMEM (high or normal glucose levels), 10% FBS and 1 % 
penicillin/streptomycin (complete growth media). At confluency, the cells were reseeded 
in CellNO trap devices at a density of 0.25-1 ×104 cells/cm2. Previously, we have reported 
the detailed fabrication and characterization of the device [152]. Briefly, silicone elastomer 
base and curing agent were dissolved in hexanes, manually cast onto 5×5 square 
polyvinylidene fluoride (PVDF) membranes and left to cure in a 50⁰C oven for 24 hours. 
The modified membrane was cut into a circle to fit into a 60mm diameter cell culture plate 
with the bottom removed forming the upper chamber. The upper chamber was sealed by 
applying toluene to the edges of the membrane and the plate. A second 60mm plate with 
drilled holes and plastic outlets attached was affixed to the upper chamber using toluene 
and reinforced with epoxy adhesive. The upper chamber was used for cell culture and the 
lower chamber was used for gaseous transfer.  To make the device suitable for cell culture, 
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freshly prepared dopamine solution in Tris-HCl buffer (2mg/ml) was added to the device 
and incubated for 12 hours. The device was rinsed several times and sterilized using 70% 
ethanol and ultraviolet light (1 hour). Prior to cell culture, the device was coated with 
gelatin solution (2mg/ml). After 24-72 hours, the cell culture media was changed and 
substituted with media containing 40µg/ml of LPS and 200 U/ml of hrIFN-Ƴ or complete 
growth media (control) under normal glucose (5.5mM) and high glucose (25mM) 
conditions. The device was placed in a standard incubator (37°C, 65% humidity, 5% CO2) 
and was connected to a calibrated nitric oxide analyzer (NOA) and the real-time NO release 
profile was measured for 24 hours.  
 
2.1.3  Cell viability assay in the CellNO trap device  
After 24 hours, the live-dead assay was carried out using 2µM calcein AM, 2µg/ml 
ethidium bromide and 10µg/ml Hoescht dye in DMEM media for 10-15 minutes. The cells 
were imaged and analyzed using an Olympus fluorescent microscope (model BX51) and 
Image J1 respectively[169]. 
 
2.1.4  Cell proliferation assays (MTT assay) 
The fibroblast cells were cultured in 96 well plates at a density of 10,000 cells per well in 
normal and high glucose cell culture conditions and stimulated with 40µg/ml and 200U/ml 
of LPS and IFN respectively. At the end of 24, 48 and 72 hours, MTT assay was performed 
according to the manufacturer’s instructions (Trevigen, 4890-025-K) with minor 
modifications. Briefly, the cell culture media was replaced with 25µl of the MTT reagent 
and incubated for 4 hours to allow the intracellular reduction of soluble yellow MTT to 
insoluble formazan dye. The MTT reagent was discarded and 100µl of Isopropyl alcohol 
was added to solubilize the dye. The absorbance was read at a wave length of 570nm using 
a Beckman Coulter microplate reader model DTX880. 
 
2.1.5  Nitrite assay  
After 24 hours of measurement in the CellNO trap device, the cell culture media from the 
cell samples under normal and high glucose conditions were collected. The triiodide assay 
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media 
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl 
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer 
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in 
the media was measured and normalized to the number of live cells.  
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2.1.6  Cell characterization 
Fibroblast cells at passage 2 were cultured in 12 well plates at a cell density of 1 ×104/cm2 
in normal and high glucose conditions. At confluency, the cells were fixed in 4% 
paraformaldehyde for 10 minutes, rinsed 3 times in phosphate buffered saline, incubated 
in blocking buffer for 90 minutes followed by the primary antibody for 18 hours at 4°C. 
The cells were rinsed 3 times in blocking buffer and incubated for 1 hour at room 
temperature with the secondary antibody, stained with 4', 6-diamidino-2-phenylindole 
(DAPI) and viewed under a fluorescent microscope.  
2.1.7  Western blot analysis  
Confluent HDFa cells were cultured in 100mm diameter tissue culture dishes, stimulated 
with 40µg/ml of LPS and 200U/ml IFN-Ƴ in normal and high glucose conditions and 
incubated for 72 hours. Mouse macrophage cells RAW 264.7 were grown to confluency 
and stimulated with 100ng/ml of LPS for 18 hours and served as the positive control. The 
cells were quickly washed in ice cold PBS, trypsinized, centrifuged and re-suspended in 
200µl of RIPA buffer in the presence of protease cocktail inhibitors. The cell lysates were 
incubated for 30 minutes on ice on a plate shaker and centrifuged at 12,000 rpm for 20 
minutes at 4°C. The supernatant was collected, and the protein concentration determined 
for each sample using Bradford assay[170]. An equal amount of loading buffer containing 
dithiothreitol was added to each sample, boiled at 100°C for 5 mins and immediately placed 
on ice for 2 mins. About 5.63-9.37µg of protein was loaded in a 7.5% SDS-PAGE gel and 
separated by electrophoresis at 100V for approximately 70 minutes. The proteins were 
transferred to immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer 
System (Bio-Rad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer 
(TBS) for 60 minutes to block nonspecific binding sites followed by incubation in TBS 
containing 0.2% of tween20 (TBS-T) and the iNOS antibody (1:1000 dilution) for 18 hours 
at 4°C. After that, the membrane was washed 4 times with TBS (0.1% tween20) and 
incubated in TBS-T with the secondary antibody (1:20000 dilution) for 1 hour then 
extensively washed in TBS, visualized by LI-COR Odyssey infrared imager and analyzed 
using Image Studio Lite Software Version 5.2.  
Statistical analysis was performed in Microsoft Excel using one-way ANOVA followed by 




2.2  Results 
2.2.1 Real-time NO detected under normal and high glucose conditions  
HDFa were cultured in the CellNO trap in either normal (5.5mM) or high glucose (25mM) 
media with and without stimulation by the inflammatory cytokine interferon gamma (IFN-
Ƴ) and bacterial endotoxin lipolysaccharide (LPS). The NO production was measured for 















The cells cultured in normal glucose media in the absence of stimulation showed a slight 
increase in NO release in the first 1 hour which peaked at 0.25×10-12 moles/min.cm2 and 
gradually went down to undetectable NO production up to 24 hours. HDFa cultured in high 
glucose media without stimulation showed an increase in NO production which peaked at 
0.56×10-12 moles/min.cm2 and remained constant for 24 hours. With stimulation, there was 
an increase in the NO production for cells cultured in normal glucose media, which peaked 
at 2.03×10-12 moles/min.cm2 and gradually dropped to 0.76×10-12 moles/min.cm2.  At 12 
hours, the NOA was disconnected and recalibrated to confirm the validity of the signal 
obtained (Arrow denoting the sudden drop in curve in Figure 1). The NO detected remained 
 
Figure 2-1. The real-time NO release from HDFa with (+) and without (-) 
stimulation cultured under normal (5.5mM) and high glucose (25mM) conditions.    
Arrow represents calibration of NOA. Image copied from [42]. The right to use this 
material is licensed under Creative Commons Attribution 4.0 International License.  
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constant at 0.44×10-12 moles/min.cm2 from 15 to 24 hours. The NO release for cells 
cultured in high glucose media followed a similar trend but with lower NO detected, which 
peaked at 0.93×10-12 moles/min.cm2 at 5 hours and gradually dropped to 0.23×10-12 
moles/min.cm2 at the end of 24 hours. The viability of the cells cultured in the CellNO trap 
device in normal and high glucose culture conditions with and without stimulation by IFN-
Ƴ and LPS was analyzed by the live/dead assay at the end of the real-time NO 















2.2.2  Nitric oxide detected from nitrite accumulation in the absence and 
presence of stimulation  
After the real-time NO measurements, the nitrite accumulated in the cell culture media was 
collected and analyzed for NO release using the triiodide assay (Figure 2-3). The nitrite 
present in the media is reduced in the presence of an acid and nucleophile to produce NO 
that is measured via chemiluminescence detection.25 Normal glucose conditions without 
stimulation had significantly lower NO levels produced from nitrite compared to normal 
glucose conditions with stimulation (0.73±0.05 versus 3.68±0.98 nmol/105 cells, p<0.05 
for n=3). In high glucose conditions, there was no statistical difference in the levels of NO 
detected without stimulation compared to stimulation with LPS/IFN (0.91±0.70 versus 
 
Figure 2-2. Cell viability detected by calcein AM and ethidium bromide for HDFa 
cultured in normal (5.5mM) glucose condition without and with stimulation, A and 
B respectively and high glucose (25mM) condition without and with stimulation C 
and D respectively. Scale bar 500µm. The results are presented as the mean ± 
standard deviation for n=3, *p<0.05. Image copied from [42]. The right to use this 
material is licensed under Creative Commons Attribution 4.0 International License.  
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4.26±2.11 nmol/105 cells). In the absence of stimulation, the NO detected from nitrite in 
normal glucose conditions compared to high glucose were not significantly different 
(0.73±0.05 vs 0.91±0.70 nmol/105 cells). Similarly, with stimulation, the NO detected from 
nitrite was not statistically different in normal glucose compared to high glucose 
















2.2.3  Comparison of real-time NO measurements and nitrite accumulation  
The total NO detected in real-time for the HDFa was integrated as the area under the curve 
(Figure 2-3) and was compared to the NO inferred from nitrite present in the cell culture 
media for the 4 treatments groups (Figure 3, N=3). lists the total amount of NO and nitrite 
produced by each test group. The results showed that the levels of real-time NO detected 
in nmol/105 was significantly higher for cells in normal glucose conditions with stimulation 
(8.42±1.16 p<0.05 for n=3) compared to without stimulation (0.48±0.31 for n=3 p<0.05). 
Similarly, under identical conditions, nitrite accumulation was significantly higher in 
normal glucose with stimulation (3.68±0.98) compared to absence of stimulation 
 
Figure 2-3, Total NO compared to nitrite accumulation determined for HDFa 
with and without stimulation under normal and high glucose conditions. (for 
n=3, there is statistically significant difference at p<0.05: * Normal glucose 
(LPS/IFN) vs Normal glucose (without stimulation); $ Normal glucose 
(LPS/IFN) vs High glucose (LPS/IFN). Image copied from [42]. The right to 
use this material is licensed under Creative Commons Attribution 4.0 





(0.73±0.05 for n=3 p<0.05). It is interesting to note that there was a higher direct NO 
measured compared to nitrite. However, high glucose conditions did not show the same 
trend. The levels of real-time NO detected with stimulation were not statistically different 
from levels of real-time NO without stimulation (3.26±0.79 and 2.85±0.91 nmol/105cells 
respectively). The NO levels obtained from nitrite measurement depicted a similar trend as 
the real-time NO measured, with no statistical difference in high glucose conditions with 
stimulation compared to high glucose without stimulation (4.26±2.11 and 0.91±0.70 
nmol/105 cells). The real-time levels of NO and nitrite detected in normal glucose 
conditions without stimulation was also not statistically different from the real time NO 
detected from the cells in high glucose conditions without stimulation (0.48±0.31 and 
3.26±0.79 vs 0.73±0.05 and 0.91±0.70 nmol/105cells respectively for n=3 p<0.05). 
Moreover, in normal glucose conditions with stimulation, the levels of real-time NO 
detected was significantly higher compared to high glucose conditions with stimulation. 
The nitrite levels were not statistically different. (8.42±1.16 and 3.26±0.79 versus 
3.68±0.98 and 4.26±2.11 nmol/105cells respectively). 
 
2.2.4  Cell characterization of HDFa cultured in normal and high glucose 
conditions 
HDFa cultured in normal and high glucose media were assessed for the presence of CD90 
(Thy-1), which is a reliable molecular marker used to identify fibroblast cells in 
culture[171]. HDFa maintained uniform staining for CD90 (Thy-1) protein in normal 
(Figure 2-4a) and high glucose conditions (Figure 2-4b) as well as the elongated and 












Figure 2-4. Immunofluorescent staining of CD90 (Thy-1) (green) in HDFa 
cultured in (A) Normal and (B) High glucose conditions. Cell nuclei (blue). 
Scale bar 200µm. Image copied from [42]. The right to use this material is 
licensed under Creative Commons Attribution 4.0 International License. 
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2.2.5  Expression of iNOS protein in HDFa cultured in normal and high 
glucose conditions  
Stimulation of fibroblasts by inflammatory cytokines and bacterial endotoxins has been 
reported to upregulate the enzyme iNOS, which is directly responsible for the production 
of NO in the cells. We assessed the levels of iNOS in HDFa cultured in normal and high 
glucose conditions with and without stimulation by western blot technique. The results 
show that overall the iNOS enzyme was present in all treatment groups and the protein 
level was very low. Macrophage cell lysates (RAW 264.7) that are known to express iNOS 
when stimulated with LPS and the mouse iNOS enzyme protein were used as positive 
controls. Faint iNOS bands can be seen in the human fibroblast cells, which appear at the 
same molecular weight as the iNOS in macrophage cells and the mouse iNOS enzyme 
(Figure 2-5).  There was no statistical difference in intensity found between the groups at 











2.2.6  Effect of normal and high glucose conditions with and without 
stimulation on the proliferation of HDFa cells. 
The proliferation rate of HDFa cells cultured in normal and high glucose conditions with 
and without stimulation by IFN-Ƴ and LPS was assessed by the MTT proliferation assay 
for 24 to 72 hours. The cells that are metabolically active reduce the tetrazolium salts in 
the MTT reagent to intracellular purple formazan crystals, which when solubilized can be 
read at an absorbance of 570nm and correlated to the proliferation of the cells[172]. In 
normal glucose conditions in the absence and presence of stimulation there was an increase 
in cell proliferation from 24 to 72 hours (0.08 to 0.14 and 0.08 to 0.12 respectively). High 
glucose conditions with no stimulation showed a slight drop in absorbance from 24 to 48 
 
Figure 2-5.  Detection of iNOS expression by western blot analysis of HDFa 
cultured in normal (NG) and high glucose (HG) conditions with (+) and without 
(-) stimulation.  Predicted band size for iNOS 131 kD and observed band size 
125kD with iNOS and RAW 264.7 (M+) as positive controls. Image copied from 
[42]. The right to use this material is licensed under Creative Commons 
Attribution 4.0 International License.  
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hours (0.07 to 0.06) and an increase to 0.15 at 72 hours. High glucose conditions with 
stimulation also showed an increase in absorbance; 0.06 at 24 hours to 0.09 at 72 hours. 
Overall, there was no statistical difference between the treatment groups at 24, 48 and 72 
















Diabetic foot ulcers remain an immense challenge with debilitating consequences and no 
adequate treatment. One of the major problems in the delayed healing of these wounds is 
the senescent nature of fibroblasts and their inability to proliferate and produce 
extracellular matrix that will aid in the migration of keratinocytes across the wound bed 
[18, 19, 168, 173, 174]. NO is widely implicated as a major player in the wound healing 
process and studies have shown that fibroblast cells produce NO [43, 44, 175, 176]. 
Whether or not this NO production is consistent even in the absence of stimulation is still 
a matter of debate. Moreover, the spatial and temporal NO production and levels that 
                                                 
2 The color to the bar graphs was changed from the original image to match the theme of the dissertation. 
 
Figure 2-6. The rate of proliferation observed in HDFa cultured in normal (5.5 
mM) and high glucose (25mM) conditions with (+) and without (-) stimulation 
from 24 to 72 hours. Three independent experiments were performed in 
triplicates (n=3). P value <0.05 was considered statistically significant. Image 
adopted from [42]. The right to use this material is licensed under Creative 
Commons Attribution 4.0 International License.  
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fibroblast cells experience is not known. The Griess assay used by previous authors only 
looks at the accumulated NO release at single point in time and this method of analysis 
measures nitrite, the stable end product of NO, not NO itself. The availability of NO to 
regulate biological functions greatly relies on various factors such as the dose, duration, 
location of NO production as well as the surrounding environment [90, 177, 178]. 
Therefore, the presence of nitrite in the cell culture media might not automatically translate 
to the level of NO generated and therefore cast doubt on the causal relationship NO may 
or may not actually have in the physiological environment [177, 178]. Wound healing is a 
dynamic process and understanding how the levels of NO production in the cells at the 
wound site changes over time is of utmost importance in exploring the possible use of NO 
to treat DFUs.  
We recorded the real-time production of NO from fibroblast cells under normal and high 
glucose conditions with and without stimulation by the bacterial endotoxin LPS and 
inflammatory cytokine IFN-Ƴ. The results obtained were then compared to the nitrite 
accumulation in the cell culture media. HDFa cells in normal glucose conditions with 
stimulation showed that significantly higher NO was detected compared to HDFa cultured 
in normal glucose conditions without stimulation (8.42±1.16 vs 0.48±0.31 nmol/105cells, 
p<0.05 for n=3). Stimulation by LPS and IFN-Ƴ is thought to upregulate the expression of 
iNOS and consequently NO production in a variety of cells including human and rodent 
fibroblasts[43, 179]. In cells such as macrophages, the production of NO acts as a host 
defense mechanism to fight off infection [29, 176]. In the normal wound healing process, 
the production of NO in fibroblast cells could act to regulate the inflammatory response at 
the wound site[43]. Alternatively, and/or additionally the production of NO could be 
associated with regulation of cell proliferation, collagen deposition or angiogenesis, which 
would show its possible role in the proliferation stage [43, 44, 176]. The NO detected from 
the cells cultured in high glucose media with stimulation was not significantly different 
from the NO detected in non-stimulated cells cultured in the same media. Interestingly, 
cells cultured in normal glucose conditions in the absence of stimulation showed barely 
detectable levels of NO while NO levels in high glucose conditions without stimulation 
was significantly higher (Figure 2-1 and 2-3). Schaffer et al. showed that fibroblast cells 
do not produce NO unless they are phenotypically altered to produce NO (wound 
fibroblasts)[44]. However, Wang et al showed that fibroblast cells spontaneously produce 
NO even in the absence of stimulation[43]. The levels of glucose used in the cell culture 
media were not specified in Wang’s study. High glucose DMEM media that is routinely 
used in culture of a variety of mammalian cells contains 25mM of glucose, which is four 
times greater than clinically relevant glucose levels (5.5-7mM)[4]. Therefore, the levels of 
glucose in the cell culture media could possibly explain the discrepancy reported in the 
literature. Cells cultured in normal glucose conditions with stimulation had significantly 
higher levels of NO detected compared to stimulated cells cultured in high glucose 
conditions (Figure 2-3).  Low levels of NO and reduced nitric oxide synthase levels in the 
diabetic state has been strongly associated with the development of DFU and impaired 
wound healing [85, 133, 180]. Schaffer et al found that low NO levels correlated with 
reduced collagen deposition and wound strength in wounded diabetic mice compared to 
healthy mice[44]. The mechanism of low NO levels in the diabetic state is still unclear but 
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evidence points toward the increased production of reactive oxygen species, such as 
superoxide, that rapidly inactivate NO, reducing its bioavailability in the cells[176, 178]. 
It is worthwhile to note that all of these studies only looked at nitrite accumulated in the 
cell culture media and not NO levels directly exposed to the surface of the cells. Our work 
has shown that the NO and nitrite levels are different under normal and high glucose 
conditions and the variability is further compounded when stimulated by NO inducing 
factors such as LPS and IFN-Ƴ.  The real-time NO measurements were compared to the 
nitrite accumulated in the cell culture media. The levels of real-time NO in normal glucose 
conditions directly correlated with the nitrite levels in the presence and absence of 
stimulation. However, high glucose conditions showed a discrepancy in real-time NO and 
nitrite levels detected (in both cases, the results were not statistically different, but the 
difference observed suggests further study is warranted).  Human aortic endothelial cells 
cultured in high glucose media has been shown to have higher levels of nitrite compared 
to cells cultured in normal glucose conditions in the absence of stimulation[181]. In another 
study, nitrite levels were suppressed in human renal endothelial and mouse schwan cells 
cultured in high glucose media compared to normal glucose media[131, 182]. The 
contradicting results obtained from these studies further illustrates that measuring only 
nitrite in the media is not sufficient to assess actual NO production and thereby attribute 
specific effects of NO on different cellular processes especially under a pathological state 
such as diabetes.  
The iNOS enzyme is thought to be upregulated when cells are stimulated by inflammatory 
mediators. We analyzed the expression of iNOS in fibroblast cells in normal and high 
glucose levels with and without stimulation by LPS AND IFN-Ƴ. The iNOS enzyme was 
found in both normal and high glucose conditions in the absence and presence of 
stimulation. Although, the expression was very low with no statistical difference between 
the 4 treatment groups. Fibroblast cells produce low amounts of NO, which could explain 
why the enzyme expression in the cells was low. To support this view, Wang showed that 
with immunocytochemical staining, only few stimulated fibroblast cells stained intensely 
for iNOS, while majority of the cells showed weak staining. Some unstimulated fibroblast 
cells also showed weak expression of iNOS.  Interestingly, histological staining on the 
dermal tissue was negative for iNOS[43]. There are various factors in the cell culture 
system that could potentially affect cell response. An example of rat hepatocytes was 
reported by Halliwell; Isolation of the cells from the tissue was found to activate iNOS in 
the absence of stimulation. The author also reported that the oxygen levels in in vitro cell 
culture systems (150mmHg) was found to be much higher than the physiological levels of 
oxygen that the cells are exposed to in vivo (1-10mmHg)[183]. These high levels of oxygen 
are associated with increased production of reactive oxygen species (ROS). Reactive 
oxygen species activate the Nuclear factor-kappa B (NF-KB) signaling pathway that leads 
to transcription of iNOS mRNA and increased expression of the iNOS enzyme[184]. 
Moreover, ROS such as superoxide rapidly react with NO forming peroxynitrite. The NO 
deficiency in the cell environment is hypothesized to activate a feedback mechanism that 
upregulates iNOS expression[185]. In regards to these findings, we speculate that other 
factors including the levels of glucose present in the cell culture environment might explain 
the differences of nitrite levels compared to the real-time levels of NO observed.  
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Nitric oxide has been shown to regulate the proliferation of cells and production of 
extracellular matrix[186, 187]. In the diabetic wound, fibroblast cells do not proliferate 
adequately and there is reduced secretion of extracellular matrix, which is a key component 
for the migration and differentiation of keratinocyte cells [18, 19, 31]. Xuan et al have 
explored the effect of high glucose on human foreskin fibroblast proliferation with no 
significant difference at up to 60mM of glucose concentration (media supplemented with 
10% FBS)[188]. In Schaffer’s study inhibition of endogenous iNOS production in mouse 
wound fibroblasts did not affect proliferation[44]. While Shi et al showed reduced 
proliferation of dermal fibroblast cells isolated from iNOS knock out mice compared to 
wild type mice[189]. The correlation between glucose levels in the presence of 
inflammatory mediators that stimulate NO production and its effect on human dermal 
fibroblast cell proliferation has not been previously reported. We looked at the effect of 
normal and high glucose conditions with and without stimulation of NO production on the 
proliferation of fibroblast cells. The results show that overall there was no statistical 
difference between normal and high glucose conditions in the absence and presence of 
stimulation from 24 to 72 hours (Figure 6).  However, the proliferation was lower in high 
glucose condition with stimulation at 48 and 72 hours compared to normal glucose with 
and without stimulation at the same time points, which prompts further investigation. 
2.4 Conclusion 
Our study showed that human dermal fibroblast cells cultured in normal glucose conditions 
with stimulation show significantly higher levels of NO compared to cells cultured in high 
glucose conditions with stimulation (8.42±1.16 and 3.26±0.79 nmols/105 cells p<0.05 for 
n=3). The nitrite levels in normal glucose conditions showed consistency with the real-time 
NO levels in normal glucose conditions with low nitrite levels in the absence of stimulation 
and a significant increase when the cells were stimulated. In contrast, there was no 
significant difference between the real-time NO measured and the nitrite levels that 
accumulated in the media in high glucose conditions with and without stimulation (Figure 
3). The nitrite level in the media is not a reliable proxy for the actual level of NO produced 
by the cell. The iNOS enzyme that produces NO when cells are stimulated with 
inflammatory mediators was expressed at a low level in all the treatment groups and the 
proliferation of fibroblast cells from 24 to 72 hours showed no statistical difference 
between normal and high glucose conditions in the absence or presence of LPS and INF-ƴ 
(Figure 5 and 6 respectively). The results presented here clearly illustrate why nitrite 
accumulation should not be used to predict NO production in cells and clearly indicates 
that real-time NO measurement is essential in providing information that will allow a more 
complete understanding of how NO may affect the proliferation, migration and formation 
of extracellular matrix in fibroblast cells as well as the NO production in other cells present 
at the wound site. If we accurately measure the actual levels of NO produced by cells 
cultured under specific conditions, including the temporal NO release profile, we can 
understand and mimic the physiological NO release at different stages of wound healing 
and different pathological states, which will facilitate a smooth transition of the wound 
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from its chronic state into resolution, consequently, shortening the time to complete healing 
of DFU.  
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3 INVESTIGATIVE STUDY OF REAL-TIME NO 
MEASUREMENTS IN WOUND FIBROBLAST CELLS IN 
NORMAL AND HIGH GLUCOSE CONDITIONS3 
Nitric oxide plays a key role in cardiovascular, immunology and respiratory 
physiopathology. In patients affected with coronary artery disease who were undergoing 
surgical procedures, the continuous administration of the NO drug nitroglycerin 
significantly reduced the risk of myocardial infarction compared to control patients[190]. 
Another study reported a very impressive reduction in mortality for patients with advanced 
heart failure treated with another NO drug isosorbide dinitrate[156]. For pediatric patients, 
exhaled NO is a non-invasive diagnostic tool to identify the severity of asthmatic episodes 
and control the administration of corticoid treatments[191].  However, its role in wound 
healing is not as well defined. Several studies have shown the beneficial effect of NO 
treatments in invitro models of migration ad cell proliferation as well as accelerated healing 
in mouse models (Table 1-3). In addition, the previous chapter and other researchers have 
demonstrated NO levels and iNOS protein expression or activity from normal human skin 
fibroblasts[43, 192]. Unfortunately, the translation of the results obtained in vivo and 
invitro have not been as straight forward in clinical application. Only one study so far has 
shown a positive effect of NO treatment in patients affected with DFU but even in this 
study, the major criticisms was that the absolute effect of NO on improved healing in these 
patients compared to patients treated with the control could not be determined [149, 193]. 
Moreover, the NO levels at the wound site was also not known [193]. A number of studies 
have reported the nitrite and nitrate levels in the wound fluid of acute and chronic wounds 
which could be an indicator to estimate correlation of NO to the healing of wounds in the 
patient[194-196]. However, it does not provide information on the timing/dose of NO 
required or which cells are responsible for the NO production at the time the samples are 
collected or when the measurements are taken.  The majority of these studies also rely on 
the Griess assay which has been proven to have a wide range of variability and low 
sensitivity [151, 152]. Cells produce varying NO levels at different stages of the wound 
healing process. The unpredictable and delicate environment of chronic wounds further 
complicates this NO production in the cells.  Without precisely comparing the levels of 
nitrite/nitrate in the wound fluid to the actual levels of NO produced from the cells present 
at the wound site, it is inaccurate if not impossible to determine the effect of NO on the 
wound healing cascade even when the NO treatment is applied. In this chapter, the NO 
levels produced from wound fibroblasts isolated from a patient with a chronic ulcer is 
determined. In addition, using highly sensitive chemiluminescence detection the nitrite 
levels in the cell culture media and at the wound site are also measured and compared to 
the real-time NO levels detected from the cells.   
                                                 
3 Part of the work in this chapter will be submitted to a journal for future publication 
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3.1  Materials and Methods4  
3.1.1  Cell culture and chemical supplies  
Primary human adult dermal fibroblasts (HDFa, ATCC® PCS-201-012™,), mouse 
macrophages (RAW 264.7), penicillin streptomycin, fetal bovine serum (FBS), phosphate 
buffered saline (PBS), and Dulbecco’s modified eagle medium (DMEM high glucose 
4500mg/l) were all purchased from ATCC (Manassas, VA). Human aortic endothelial cells 
were purchased from Gibco life technologies (Carlsbad, CA).  DMEM (no glucose), 
sodium pyruvate and Hoescht dye were obtained from Fischersci (Hanover Park, IL). D-
(+)-Glucose, Lipopolysaccharide pseudomonas aeroguinosa (LPS), Calcein-AM, protease 
inhibitor cocktail, mouse nitric oxide synthase and dopamine-HCl were purchased from 
Sigma-Aldrich (St. Louis, MO). Ethidium bromide was acquired from Invitrogen (Grand 
Island, NY). Human recombinant Interferon gamma (hrIFN-Ƴ) was purchased from 
GenScript (Piscataway, NJ). The primary and secondary antibodies against CD90/Thy1 
(ab23894) protein and nitric oxide synthase (PAN 2977) were purchased from Abcam 
(Cambridge, MA) and cell signaling technology (Danvers, MA) respectively. The 7.5% 
SDS polyacrylamide gels and gelatin were acquired from Bio-Rad (Hercules, CA). The 
Odyssey western blot starter kit 2 was obtained from LI-COR (Lincoln, NE). Silicone 
elastomer base and curing agent (Dow Corning Sylgard®184) were obtained from ML 
Solar LLC (Campbell, California). Sodium nitrite and nitrate, potassium iodide, 
Aspergillus nitrate reductase, nicotinamide adenine dinucleotide phosphate hydrogen 
(NADPH), flavine adenine dinucleotide (FAD) potassium mono and dibasic phosphate 
(KHPO4) were all purchased from Millipore sigma (St. Louis, MO, USA). Glacial acetic 
acid was obtained from BDH analytical chemicals VWR (Batavia, IL, USA).  
3.1.2  Biopsy tissue and wound fluid collection  
A biopsy sample and wound fluid were obtained from a patient in an ongoing clinical study 
(IRB Number 1146644-4)) following procedures approved by the institutional review 
board of Michigan Technological University. The sample was immediately processed for 
cell isolation by a procedure adopted from Vangipuram et al [197]. 
3.1.3  Cell characterization 
The wound cells at passage 3 were cultured in 12 well plates at a cell density of 1 ×104/cm2 
in normal (5.5 mM) and high glucose (25 mM) conditions. At confluency, the cells were 
fixed in 4% paraformaldehyde for 10 minutes, rinsed 3 times in phosphate buffered saline, 
incubated in blocking buffer for 90 minutes followed by the primary antibody for 18 hours 
at 4°C. The cells were rinsed 3 times in blocking buffer and incubated for 1 hour at room 
                                                 
4 The materials and methods were adopted from chapter 2 [42]. The rights to use the content is presented in 
appendix C and licensed under Creative Commons Attribution 4.0 International License.  
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temperature with the secondary antibody, stained with 4', 6-diamidino-2-phenylindole 
(DAPI) and viewed under an Olympus fluorescent microscope (model BX51). 
 
3.1.4 Real time NO measurements from wound fibroblasts 
Primary wound dermal fibroblasts from passage 2-5 were cultured and expanded in 
conventional cell culture plates (100mm) in DMEM (high or normal glucose levels), 10% 
FBS and 1 % penicillin/streptomycin (complete growth media). At confluency, the cells 
were reseeded in the CellNO trap devices at a density of 0.25-1 ×104 cells/cm2. The devices 
were made using the procedure that was previously described[152]. After 24-72 hours, the 
cell culture media was changed and substituted with media containing 40µg/ml of LPS and 
200 U/ml of hrIFN-Ƴ or complete growth media (control) under normal glucose (5.5mM) 
and high glucose (25mM) conditions. The device was placed in a standard incubator (37°C, 
65% humidity, 5% CO2) and was connected to a calibrated nitric oxide analyzer (NOA) 
and the real-time NO release profile was measured for 24 hours.  
3.1.5  Cell viability assay in the CellNO trap device  
After 24 hours, the live-dead assay was carried out using 2µM calcein AM, 2µg/ml 
ethidium bromide and 10µg/ml Hoescht dye in DMEM media for 10-15 minutes. The cells 
were imaged and analyzed using an Olympus fluorescent microscope (model BX51) and 
Image J1 respectively[169]. 
3.1.6  Nitrite assay  
After 24 hours of measurement in the CellNO trap device, the cell culture media from the 
cell samples under normal and high glucose conditions were collected. The triiodide assay 
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media 
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl 
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer 
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in 
the media was measured and normalized to the number of live cells.  
3.1.7  Western blot analysis  
Confluent wound fibroblast cells cultured in 100mm diameter tissue culture dishes were, 
stimulated with 40µg/ml of LPS and 200U/ml IFN-Ƴ in normal and high glucose 
conditions and incubated for 72 hours. Mouse macrophage cells RAW 264.7 grown to 
confluency and stimulated with 1ug/ml of LPS for 18 hours and human aortic endothelial 
cells served as positive controls for iNOS and eNOS respectively. The cells were quickly 
washed in ice cold PBS, trypsinized, centrifuged and re-suspended in 200µl of RIPA buffer 
in the presence of protease cocktail inhibitors. The cell lysates were incubated for 30 
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minutes on ice on a plate shaker and centrifuged at 12,000 rpm for 20 minutes at 4°C. The 
supernatant was collected, and the protein concentration determined for each sample using 
Bradford assay[170]. An equal amount of loading buffer containing dithiothreitol was 
added to each sample, boiled at 100°C for 5 mins and immediately placed on ice for 2 mins. 
Approximately 10-14µg of protein was loaded in a 7.5% SDS-PAGE gel and separated by 
electrophoresis at 100V for approximately 70 minutes. The proteins were transferred to 
immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer System (Bio-
Rad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer (TBS) for 
60 minutes to block nonspecific binding sites followed by incubation in TBS containing 
0.2% of tween20 (TBS-T) and the iNOS antibody (1:1000 dilution) for 18 hours at 4°C. 
After that, the membrane was washed 4 times with TBS (0.1% tween20) and incubated in 
TBS-T with the secondary antibody (1:20000 dilution) for 1 hour then extensively washed 
in TBS, visualized by LI-COR Odyssey infrared imager and analyzed using Image Studio 
Lite Software Version 5.2.  
 
3.1.8  Nitrite and nitrate measurements from wound fluid   
Swabs containing wound fluid were sterilized under ultraviolet light for 1 hour prior to 
experiments performed. The swabs were soaked in 500 µl of deionized water and sonicated 
for 10 minutes. These samples were prepared for nitrite and nitrate measurements using a 
procedure adopted from Gilliam et al with minor modifications[198]. Briefly for each 
nitrite standard solution, final reaction volume containing 40 µl of 0.14M of potassium 
phosphate buffer pH 7.5, 35 µl of deionized water and 25 µl nitrite standard was prepared. 
For the nitrate standards, a final reaction volume containing 40µl of 0.14M KHPO4 buffer 
(pH 7.5), 26.8µl of deionized water, and 2.5 µl OF 100 µM FAD, 4µl OF 2.5mM NADPH, 
25 µl of standard and 1.7 µl of 3.5U/ml of nitrate reductase was prepared. The samples 
were left to incubate for 24 hours at room temperature to convert all nitrate into nitrite. 
3.1.9 Nitrite and nitrate standards preparation 
Stock solutions of nitrite and nitrate standards were prepared to a final concentration of 10 
mM in deionized water. The stock solutions were diluted in deionized water to make 
standard solutions ranging from 0- 50 µM and 0-150µM.  The solutions were prepared as 
previously described.   
3.1.10  Blinded concentrations of nitrite and nitrate  
Three standard samples containing different ratios of nitrite and nitrate concentrations were 
prepared using the same procedure for the nitrite and nitrate calibration standards. Another 
researcher was blinded to the concentrations of these standards during measurements. 
40 
3.1.11  Chemiluminescence detection method for nitrite measurements  
50 µl of each of the standards and samples, was injected into a vial containing a bubbling 
solution of 300 µl of glacial acetic acid and 120 µl potassium iodide in order to reduce all 
the nitrite into nitric oxide (NO). The vial was connected to a calibrated Sievers nitric oxide 
analyzer 280i (NOA) (Zysense, LLC, Boulder, CO, USA) to measure the total NO released. 
The background signal from the NOA before injecting the standards and samples was 
averaged for 1 minute and subtracted from each data point measured prior to integrating 
the area under the curve. Two calibration curves were determined for nitrite and nitrate 
standards. The nitrite calibration curve was used to calculate the concentration in the 
blinded standards and clinical samples. The concentration of nitrate was determined as the 
difference in the nitrite and the total nitrite measured from the nitrate samples. The 
experiments were performed as 3-5 replicates and the data obtained was analyzed in 
Microsoft Excel. 
3.2 Results  
3.2.1 Characterization of cells isolated from biopsy sample cultured in 
normal and high glucose conditions 
The migration of the cells from the biopsy tissue took approximately 3 weeks. The cells 
appeared to grow well and different cell populations could be observed within the cell 
culture (Figure 2-1).   
 
Figure 3-1. The cell isolation from a human skin biopsy sample. Arrows represent 
different cell populations observed 
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Cells at passage 3 cultured in 12 well plates in normal and high glucose conditions for 24 
hours were elongated and spindle shaped which is commonly associated with confluent 
fibroblast cells (Figure 3-2A and 3-2B). In addition, the cells showed uniform staining of 
CD90, a characteristic marker frequently used to identify fibroblasts in primary cultures 
(Figure 3-2 C and 3-4 D).  
 
 
Figure 3-2. The characterization of cells isolated from the biopsy tissue. Phase contrast 
images showing morphological appearance of isolated cells cultured in (A) normal 
(5.5mM) and (B) high glucose (25mM) conditions. Immunofluorescent staining of Green 
(CD90) and Blue (cell nuclei) for the cells cultured in (C) normal and (D) high glucose 
conditions. Scale bar 400µM 
 
3.2.2        Real- time NO measurements of wound fibroblasts cultured in 
normal and high glucose conditions  
The real-time NO release in wound fibroblasts cultured in normal and high glucose 





















 Cells cultured in normal glucose media without stimulation did not show any detectable 
NO measurements. When the cells were stimulated with inflammatory mediators, there 
was an increase in NO detected after 1 hour that peaked at 24 hours (1.03×10-11 (moles/ 
(min.cm2))/105cells). The cells cultured in high glucose without stimulation showed very 
low NO levels which also peaked at 24 hours (2.59×10-12(moles/(min.cm2))/105cells). 
When stimulated there was no detectable NO measured up to 20 hours. At this time point, 
there was an increase in NO detected which peaked at 24 hours but still lower than normal 
glucose with stimulation (5.27×10-12(moles/(min.cm2))/105cells). The wound fibroblasts 








Figure 3-3. The real-time NO profile detected in wound fibroblasts cultured in 















3.2.3  Nitric oxide detected from nitrite accumulation in the absence and 
presence of stimulation 
At the end of the real-time NO measurements, the media in the cell cultures was collected 
and assessed  for nitrite accumulation using the triiodide assay [74]. The NO detected from 
the total nitrite accumulated in the media was compared to the integrated area under the 
curve for the real time NO detected from the cells (Figure 3-5). The cells cultured in 
normal glucose without stimulation showed absence of real time NO levels which was 
increased when stimulated (4.08±3.38nmol/105 cells). There was nitrite detected in normal 
glucose without stimulation, although lower compared to stimulated cell cultures 
(0.77±1.34 vs 1.52±2.64 nmol/105 cells). In high glucose conditions, both total NO and 
nitrite in the media could be detected in the absence of stimulation (0.61±1.06 vs 0.77±0.48 
nmol/105 cells). However, with stimulation in high glucose conditions, there was no 
detectable accumulation of NO or nitrite after 24 hours.  Overall there was no significant 





Figure 3-4. Cell viability detected by calcein AM and ethidium bromide for wound 
fibroblasts cultured in normal (5.5mM) glucose condition without and with 
stimulation, A and B respectively and high glucose (25mM) without and with 













3.2.4  Western blot analysis for iNOS, eNOS and NF-κβ protein 
quantification  
Wound fibroblasts at passages 2-4 were cultured in 100mm diameter dishes and at 
confluency were stimulated with 200U of IFN-Ƴ and 40 µg/ml of LPS for 72 hours. 
Western blot analysis showed absence of inducible NOS in all treatment groups (Figure 
3-6).  An independent experiment was run to determine the presence of constitutively 
expressed NOS isoforms (eNOS and nNOS) using a universal NOS antibody that can detect 
all three isoforms. RAW 264.7, human aortic endothelial cells were used as a positive 
control for iNOS and eNOS respectively. The results showed faint bands at the predicted 
molecular weight of eNOS and these bands were the same band size as the positive control 
(HAEC). Endothelial nitric oxide synthase levels were low in unstimulated wound 
fibroblasts cultured in normal and high glucose without stimulation compared to stimulated 
cells and in both cases the levels were higher in high glucose compared to normal glucose 
conditions (Figure A1). In addition, the protein levels of the transcription factor NF-κβ that 
is upstream in the pathway that leads to iNOS expression was determined and was found 
to be increased in stimulated wound fibroblasts cultured in normal and high glucose 
conditions compared to unstimulated cells. The levels were higher in high glucose with 




Figure 3-5. The total NO compared to nitrite accumulation in the cultured 
media determined for wound fibroblasts cultured under normal (NG) and high 













3.2.5 Nitrite and nitrate measurements from wound fluid  
Nitrite and nitrate standard solutions were prepared with concentrations of 0-50 µM. The 
nitrate was converted to nitrite by the enzyme nitrate reductase and the NO released from 
the nitrite solutions was measured and used to obtain two calibration standard curves. 
Figure 3-7 shows the linearity of the curves obtained. The results clearly indicate that the 
enzyme converted almost all the nitrate into nitrite. Chemiluminescence detection showed 
a minimum sensitivity level of 0.05-0.1µM of nitrite (Figure A3). The enzyme converted 
nitrate concentrations of up to 150µM which was observed from the linearity and 










Figure 3-6 Western blot analysis to determine iNOS protein in wound 
fibroblasts cultured in normal glucose (NG) and high glucose (HG) in the 
absence (-) and presence (+) of stimulation (n=3). GAPDH was used as 












Three samples containing a combination of standard nitrite and nitrate concentrations were 
prepared and processed. The nitrate in the samples was converted into nitrite by the enzyme 
nitrate reductase and the nitrate was calculated by subtracting the total nitrite from the 
nitrite only preparations. The researcher was blinded to the concentrations in the samples 
during measurements. This was performed in order to determine the accuracy of our 
method to assess unknown levels of nitrite/nitrate present in clinical wound swab samples. 
Three ratios were prepared; 2:1 (T19), 1:1 (T20) and 1:2 (T21) of nitrite to nitrate 
concentrations. The analysis showed (Figure 3-8) that two of the samples (T20 and T21 
maintained the theoretical ratio that was prepared before processing and taking 
measurements while T 21 showed a slight deviation of the ratio prepared (2.3:1 versus 2:1).   
 Figure 3-7. Calibration curves obtained from nitrite and nitrate standards for 
concentrations ranging from 0-50µM. 
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Figure 3-8. Samples containing combination of known standard nitrite and nitrate 
concentration. 2:1 (T19), 1:1 (T20) and 1:2 (T21) of nitrite to nitrate concentrations. For 
n=3 
 
The data proves that it is reliable to use this method to determine nitrite and nitrate levels 
present in wound fluid. The swab with fluid that was obtained from the wound site from 
which the cells were isolated was analyzed for nitrite and nitrate using the method 
described above. The results (Figure 3-9) showed a higher nitrite concentration in the 
wound fluid compared to nitrate for 5 independent replicate measurements (60.25±1.79 
µM vs 27.42±3.91 µM). Moreover, the NO detected was 1000-fold higher than the total 























3.3  Discussion  
The goal of this study, was to establish a protocol that can be used to assess the levels of 
NO produced by cells in the wounds of patients affected with DFU and compare the NO 
levels to the nitrite/nitrate present in the wound bed in order to clearly delineate the 
bioavailability of NO in the chronic wound.  We were able to successfully isolate, expand 
and culture wound fibroblasts from a biopsy sample obtained from a patient with an ulcer. 
Establishing primary cultures from chronic wounds is challenging and, in some cases, the 
cells have a lower proliferative capacity and altered morphology compared to normal 
fibroblasts[199-202]. Overall, although the cell yield was lower than normal fibroblasts, 
the cells obtained in this study exhibited morphology and markers characteristic to 
fibroblasts and the cells maintained relatively uniform growth function through passage 5. 
Furthermore, the wound fibroblasts achieved greater than 95% viability in the NO 
measurement device (Figure 3-4). The real-time NO levels could be detected in the cells 
using this system. The cells cultured in normal glucose media without stimulation showed 
absence of NO detected which was similar to normal skin fibroblasts. When stimulated 
with inflammatory mediators, there was an increase in NO detected however the NO profile 
was markedly different (Figure 3-3) and lower compared to normal fibroblasts cultured 
under the same conditions (Figure 2-1). The sample used in this chapter is part of an 
ongoing blinded clinical study (IRB 1146644-1) and therefore, it is interesting to note that 
the cells obtained were isolated from the biopsy of a non-diabetic patient with a chronic 
wound aged one year and 8 months. Studies have suggested that there is a deficiency or 
reduced availability of NO in chronic wounds both diabetic and non-diabetic[85, 161, 203]. 
In addition, chronic wounds have a common finding which is the persistent production of 
                   Figure 3-9. Total NO released from the nitrite and nitrate concentration measured 
from wound swab sample. For n=5 at p< 0.05 * represents statistical significance 
between the groups.  
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reactive oxygen /nitrite species as well as a reduced antidefense mechanism[203]. This is 
the first study to report the levels of real-time NO produced from cells isolated from a 
human chronic wound and our preliminary data has shown a possible reduction of NO 
produced from wound fibroblasts obtained from chronic wound tissue. We also measured 
the change in the NO detected when the cells were cultured in high glucose conditions with 
and without stimulation and the results also showed suppressed NO levels compared to 
normal skin fibroblasts. The NO levels measured after 24 hours was compared to the nitrite 
present in the cell culture media. In normal glucose conditions, the trend remained 
consistent with normal skin fibroblasts with the data showing increased NO and nitrite 
levels for stimulated cells compared to unstimulated cells (Figure 3-4). A key finding was 
detectable nitrite (0.77±1.34 nmols/105 cells) in normal glucose without stimulation and 
absence of real-time NO under the same treatment conditions.  During the normal wound 
healing process, cells such as the immune cells, endothelial cells, fibroblasts and 
keratinocytes produce proportional amounts of ROS (superoxide)[203]. Superoxide reacts 
very rapidly with NO to produce the more toxic compound peroxynitrite that can be 
oxidized into nitrite/nitrate as well[129]. Fortunately, antioxidant mechanisms are present 
to modulate the production and levels of superoxide in order to increase the bioavailability 
of NO to the cells. For example, the enzyme superoxide dismutase present at the wound 
will convert superoxide into hydrogen peroxide and the enzyme catalase will then convert 
the hydrogen peroxide into oxygen and water[203]. Our finding suggests that there might 
be high levels of ROS that surpass the antioxidant mechanisms in chronic wound cells that 
leads to absence of NO detection and the presence of nitrite.  High glucose conditions 
without stimulation showed low levels of nitrite similar to the real time NO measurements 
under the same conditions. However, there was neither nitrite nor total NO detected for the 
cells cultured in high glucose with stimulation (Figure 3-5). Western blot analysis was 
performed for the wound fibroblasts to assess the upregulation the NOS enzymes known 
to be responsible for NO production. The data showed absence of the inducible nitric oxide 
synthase enzyme (Figure 3-6).  Although, the NF-κβ protein which is the principal 
transcription factor that activates the genes responsible for the production of iNOS was 
upregulated with increased levels in stimulated cells (Figure A-2). Whether this could be 
an indication of an interference in the pathway that leads to upregulation of the iNOS 
enzyme still needs to be determined. We also assesed protein levels of constitutively 
expressed NOS isoforms using a universal NOS antibody and faint bands were observed 
that corresponded to the molecular weight of eNOS. The results showed a trend for higher 
protein levels in stimulated compared to non-stimulated wound fibroblasts (Figure A-1). 
Endothelial nitric oxide synthase and its activity has been identified in cultured human skin 
fibroblast cells[43, 204]. It has also been proposed as a mechanism to increase ROS in 
diabetic and chronic wounds through its uncoupling from the NO pathway to produce 
superoxide instead[203]. Only one replicate measurement was run to determine the 
presence of constitutively expressed NOS isoform enzymes and we cannot draw a 
definitive conclusion with the results so far. However, it shows that further studies will 
need to performed to determine the role of eNOS in the dysregulation of chronic wounds. 
There was no statistical difference obtained within the groups for the real time/nitrite 
measurements and a large variation in NO and nitrite detected for 3 independent 
experiments was observed.  This could be attributed to the altered state of the cells that 
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resided in a persistent chronic state for over a year. Caley et al[201] reported a reduced 
reproducibility in cells isolated from chronic wounds and the reason is that the cells take 
on a distinct phenotype in the chronic wound bed that is ultimately retained even in invitro 
cell culture. To support this hypothesis Schaffer et al [44] assessed NO/nitrite production 
in cells isolated from a wounded rat model. The cells isolated from the wound only 
produced NO in the first two passages. This phenomenon might also be observed in 
primary cells obtained from a chronic wound.  
Experiments were performed to determine the nitrite/nitrate levels present in the wound 
bed. The studies in the literature analyze the NO levels by looking at the nitrite/nitrate 
present in the plasma/urine of the patient as well as the metabolites of the substrate arginine 
that is present in the wound fluid[205, 206] while others use the fluid obtained in  animal 
wound models to predict the NO state and function .The data gives an overview of the NO 
levels in the pathological states and how it could possibly affect the healing wound but it 
does not give an accurate assessment of the NO levels or even nitrite/nitrate that is actually 
present in a clinically relevant wound model. Besides, the Griess assay was mainly used to 
determine these nitrite levels and it has been shown to have  a low sensitivity (0.5µM) 
[207] and the presence of blood components such as hemoglobin could greatly interfere 
with the results obtained[208].  We established an effective method to analyze the 
nitrite/nitrate present in the fluid of chronic wounds. The protocol used was adopted from 
Gilliam et al[198] with some modifications. Nitrite and nitrate standard solutions with 
equal concentrations were prepared and the nitrate was converted to nitrite by the enzyme 
nitrate reductase. The nitrite was reduced to NO using the triiodide assay and the NO 
released was measured using the most highly sensitive method for NO detection 
(chemiluminescence). The results showed complete conversion of nitrate into nitrite 
(Figure 3-6). To determine the accuracy of the method, 3 blinded samples containing 
standard concentrations of both nitrite and nitrate were prepared and measured. The results 
showed that the theoretical ratio matched up the experimental ratio obtained with slight 
deviation in one of the samples (Figure 3-7) The detection limit was as low as 0.05-0.1µM 
and for the enzyme concentration used, a linear response was maintained up to 150µM 
(Figure A 3) validating that we can use this method to analyze low and high nitrite 
concentrations in wound fluid samples. We determined the nitrite/nitrate levels in the 
wound fluid obtained from a human chronic wound (Figure 3-8). The nitrite in the wound 
bed was found to be in the micromolar range which is one thousand-fold higher than the 
NO that was detected in the cells (Figure 3-5). This confirms that tracking nitrite/nitrate 
accumulation cannot be used to determine actual NO production during wound healing. 
The rate of nitrite/nitrate clearance from the wound fluid is unknown. As NO decomposes, 
nitrite and nitrate will accumulate in fluid, the wound bed will influence how quickly fluid 
and ions are removed and this removal rate will likely change during the course of wound 
healing. Additionally, the wound fluid is collected after the biopsy was obtained. This 
might have provoked the hemostatic phase of wound healing, consequently increasing NO 
production at the wound site. The data further proves that there are many factors that can 
result in increased nitrite levels when the sample is collected at a specific time point and it 
is precisely why it’s not accurate to rely only on these NO metabolites to predict the NO 
role in a given pathology. The high nitrite concentration measured could also support a 
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possible reduction of NO bioavailability to cells in and surrounding the wound bed from 
high ROS levels and low antioxidants. There is also the possibility of other cells such as 
the immune cells that persist in the chronic wound that are responsible for the high nitrite 
levels measured. The levels of nitrite were significantly higher compared to the nitrate level 
(60.25±1.79 µM vs 27.42±3.91 µM). Hemoglobin is an effective scavenger of NO.  It 
reduces NO concentration by oxidizing NO predominantly into nitrate. Therefore, in the 
event of an increased hemostatic response, it is expected that NO produced would oxidize 
primarily to nitrate but this was not the case. The toxic NO metabolite peroxynitrite 
oxidizes significantly to nitrite at a pH of 7.5[129]. At lower pH levels (pH 3) it is 
predominantly oxidized to nitrate. Chronic wounds have been reported to have pH values 
ranging from 7.19-8.5 that is also taken as an indicator of the delayed healing status of the 
wound[209]. The pH at the wound used in this chapter was not determined in our study 
and it’s also not know whether higher pH values (>7.5) or other components in the wound 
environment will result in more decomposition of peroxynitrite into nitrite. However, our 
data shows that further study on the metabolic fate of peroxynitrite is warranted. 
3.4  Conclusion 
In this chapter, the real-time NO and nitrite levels detected in wound fibroblasts isolated 
from a chronic wound cultured in normal and high glucose conditions for a duration of 24 
hours was assessed. The results show that the NO production is altered in fibroblasts 
isolated from a chronic wound tissue. In addition, we validated a method to determine the 
nitrite/nitrate levels present in wound fluid. The nitrite/nitrate levels in wound fluid was 
1000-fold higher than the NO levels measured in the cells which suggests that there is a 
dysregulation in NO levels in chronic wounds that could explain the delayed healing in the 
patient.  The work presented proves that we can determine the real-time NO levels from 
cells isolated from patients with chronic wounds as well as the nitrite/nitrate present at the 
wound site. Combining the data obtained from these two methods of analysis coupled with 
measuring protein levels of the different enzymes/factors that might affect the 
bioavailability of NO will indeed offer better insight on the exact timing, dose and duration 
of NO treatment that is required to restore the milieu interieur in the chronic wound and 
lead to complete healing for patients.  
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4 INVESTIGATIVE STUDY OF REAL-TIME NO 
MEASUREMENTS IN MOUSE MACROPHAGE CELLS 
(RAW 264.7) IN NORMAL AND HIGH GLUCOSE 
CONDITIONS5  
Macrophages are one of the most important cell types during wound healing. They are the 
guardians of the innate immune system and are involved in initiating and resolving the 
inflammatory response. Macrophages also facilitate the transition of the wound from the 
inflammatory to the proliferative phase and have the capacity to influence all other phases 
of the wound healing process. This was demonstrated in macrophage deficient wound mice 
models. The wounds resulted in reduced collagen synthesis and granulation formation, 
insufficient secretion of growth factors, low levels of myofibroblast cells and ultimately 
delayed wound closure[210]. The multifunctional roles of macrophages are possible 
because they can take on different functional phenotypes during the progression of wound 
healing. The most commonly known phenotypes are the classical (M1) and alternative 
(M2) macrophages. The former being pro-inflammatory and the latter anti-
inflammatory[211]. On activation by inflammatory cytokines and/or bacterial products, 
M1 secrete large amounts of reactive oxygen and nitrogen species as well as other 
inflammatory mediators which act to disinfect the wound and recruit cells to the wound 
site[31, 32]. The M1 are also phagocytic cells and act by clearing the wound bed of cell 
debris. When the wound bed is appropriately prepared, the M1 phenotype changes to an 
M2 phenotype that does not produce ROS /RNS. Instead, these cells resolve the 
inflammatory process and are mainly involved in promoting cell proliferation and tissue 
repair by producing growth factors VEGF, TGF-β and Insulin like growth factor-1[210] 
This change is critical for the transition of the wound from the inflammatory to the 
proliferative stage of wound healing. The alteration in the phenotypes of macrophages has 
been greatly linked to the development of DFU and it is reported that factors and 
mechanisms that regulate glucose and lipid metabolism facilitate the change from M1 to 
M2 [122] Moreover, paracrine factors produced from both M1 and M2 macrophages have 
been shown  to influence the phenotype and function of fibroblast cells [212]. Human skin 
fibroblasts cultured in M1 conditioned media expressed more pro inflammatory genes and 
produced more ECM degrading enzymes compared to the fibroblasts cultured in 
conditioned M2 media which exhibited increased ECM production and proliferation 
potential. Chronic wounds are often stalled in the inflammatory phase of wound healing 
and the altered phenotype and function of macrophages could explain the persistence of 
DFU in this phase [213]. Nitric oxide is the principal compound produced from M1 
macrophages. Previous studies from our lab have clearly elucidated the real- time NO 
profile from the macrophage cell line RAW 264.7[152]. The nitrite accumulation and 
protein levels in these macrophages has also been well characterized from these cells.  
Additionally, RAW 264.7 cells have been widely used in the literature as a positive control 
to validate NO production in cells[132, 214, 215]. However, the real-time NO profile of 
                                                 
5 The work in this chapter will be submitted to a journal for future publication. 
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RAW 264.7 cells cultured in normal and high glucose conditions and how it compares with 
the nitrite has not been previously explored. In addition, RAW 264.7 is also phenotypically  
and functionally stable through 30 passages [215]. Therefore, it allows us to validate the 
results from the two previous chapters that have shown that high glucose suppresses NO 
produced from the cells. A detailed understanding of the dynamic changes of NO produced 
from macrophages cultured in normal and high glucose conditions might be the key that 
unlocks the door to accelerated healing in chronic wounds such as DFU.   
 
4.1 Materials and Methods6  
4.1.1 Cell culture and chemical supplies  
Mouse macrophage cell line RAW 264.7 (ATCC TIB-71), penicillin streptomycin, fetal 
bovine serum (FBS), phosphate buffered saline (PBS), and Dulbecco’s modified eagle 
medium (DMEM high glucose 4500mg/l) were all purchased from ATCC (Manassas, VA). 
DMEM (no glucose), sodium pyruvate and Hoescht dye were obtained from Fischersci 
(Hanover Park, IL). Lipopolysaccharide pseudomonas aeroguinosa (LPS), Calcein-AM, 
protease inhibitor cocktail and dopamine-HCl were purchased from Sigma-Aldrich (St. 
Louis, MO). Ethidium bromide was acquired from Invitrogen (Grand Island, NY). The 
7.5% SDS polyacrylamide gels, GAPDH antibody (VPA00187) and gelatin were acquired 
from Bio-Rad (Hercules, CA). Nitric oxide synthase antibody (PAN) (2977) was purchased 
from cell signaling technology (Danvers, MA). The secondary antibodies; IR dye®680RD 
and 800CW goat anti-mouse and anti-rabbit, Odyssey blocking buffer, immobilon-FL 
transfer membrane and the chameleon duo pre-stained protein ladder were obtained from 
LI-COR (Lincoln, NE).  Silicone elastomer base and curing agent (Dow Corning 
Sylgard®184) were obtained from ML Solar LLC (Campbell, California).  
 
4.1.2 Real time NO measurements from macrophages cells RAW 264.7 
RAW 264.7 at passage 15 were cultured and expanded in conventional cell culture plates 
(100mm) in DMEM (high or normal glucose levels), 10% FBS and 1 % 
penicillin/streptomycin (complete growth media). At confluency, the cells were reseeded 
in the CellNO trap devices at a density of 0.25-1 ×105 cells/cm2. The detailed fabrication 
and characterization of the device has been previously reported [152]. After 24-72hours, 
the cell culture media was changed and substituted with media containing 1µg/ml of LPS 
or complete growth media (control) with normal glucose (5.5mM) and high glucose 
                                                 
6 The materials and methods were adopted from chapter 2 [42]. The rights to use the content is presented in 
appendix C and licensed under Creative Commons Attribution 4.0 International License  
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(25mM) concentrations. The device was placed in a standard incubator (37°C, 65% 
humidity, 5% CO2) and was connected to a calibrated nitric oxide analyzer (NOA) and the 
real-time NO release profile was measured for 24 hours.  
 
4.1.3  Cell viability assay in the CellNO trap device 
After the real-time NO measurements, a live-dead assay was carried out using 2µM calcein 
AM, 2µg/ml ethidium bromide in PBS for 10-15 minutes. The cells were imaged and 
analyzed using an Olympus fluorescent microscope (model BX51) and Image J1 
respectively[169]. 
 
4.1.4  Nitrite assay  
After 24 hours of measurement in the CellNO trap device, the cell culture media from the 
cell samples under normal and high glucose conditions were collected. The triiodide assay 
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media 
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl 
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer 
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in 
the media was measured and normalized to the number of live cells.  
 
4.1.5 Western blot analysis  
Confluent RAW 264.7 cells cultured in 100mm diameter tissue culture dishes were 
stimulated with 1µg/ml of LPS in normal and high glucose conditions and incubated for 
24 hours. The cells were scraped, centrifuged and re-suspended in 200µl of RIPA buffer in 
the presence of protease cocktail inhibitors. The cell lysates were incubated for 30 minutes 
on ice on a plate shaker and centrifuged at 12,000 rpm for 20 minutes at 4°C. The 
supernatant was collected, and the protein concentration determined for each sample using 
Bradford assay[170]. An equal amount of loading buffer containing dithiothreitol was 
added to each sample, boiled at 100°C for 5 mins and immediately placed on ice for 2 mins. 
About 30 µg of protein was loaded in a 7.5% SDS-PAGE gel and separated by 
electrophoresis at 100V for approximately 70 minutes. The proteins were transferred to 
immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer System (Bio-
Rad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer (TBS) for 
60 minutes to block nonspecific binding sites followed by incubation in TBS containing 
0.2% of tween20 (TBS-T), GAPDH and the iNOS antibodies (1:1000 and 1:10000 dilution 
respectively) for 18 hours at 4°C. After that, the membrane was washed 4 times with TBS 
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(0.1% tween20) and incubated in TBS-T with the secondary antibody (1:20000 dilution) 
for 1 hour then extensively washed in TBS, visualized by LI-COR Odyssey infrared imager 
and analyzed using Image Studio Lite Software Version 5.2.  
Statistical analysis was performed in Microsoft Excel using a student’s t-test with statistical 
significance set at a 95% confidence level (P<0.05).  
4.2  Results  
4.2.1 Real-time NO measurements from the macrophage cell line RAW264.7  
Raw 264.7 cells cultured in the CellNO trap device in normal and high glucose media 
showed absence of NO in unstimulated cells (Figure 4-1). After stimulation by the bacterial 
product LPS (1µg/ml), there was a steady increase in NO detected after 3 hours in normal 
glucose conditions which peaked at 12.5 hours (9.737×10-12(moles/(min.cm2))/106cells) 
with a gradual reduction in NO detected at 24 hours (3.645×10-12 (moles/(min 
.cm2))/106cells). In high glucose conditions, NO was detected after 4 hours and it peaked 
at 14.5 hours (2.212×10-12 (moles/(min.cm2))/106cells) and gradually decreased to (1.734 
×10-12 (moles/(min.cm2))/106cells) at the end of 24 hours. The NO detected in normal 
glucose condition was significantly higher compared to high glucose conditions as 














Figure 4-1. The average real- time NO surface flux from RAW 264.7 
cultured in normal (5.5mM) and high glucose (25mM) media without (-) 
and with (+) stimulation by LPS (1µg/ml)   
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4.2.2  Nitric oxide detected from nitrite accumulation in the absence and 
presence of stimulation 
The nitrite accumulated in the media at the end of the real-time NO measurements was 
analyzed using the triiodide assay[74]. In unstimulated cells, the levels of nitrite was very 
low compared to stimulated cells in normal and high glucose conditions (2.32±0.32 vs 
1.22±1.19 nmol/106 cells for n=3).  When stimulated, the nitrite detected in normal glucose 
conditions was slightly higher than the nitrite detected in high glucose but not statistically 



















Figure 4-2  The comparison between the accumulated real-time NO and the nitrite 
measurements for normal (NG) and high (HG) glucose the absence (-) and presence 
(+) of stimulation. For n=3, * represents statistical difference in real time NO in 
NG+ and HG +. # represents statistical difference in real-time and nitrite in NG+ 
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4.2.3 The cell viability for RAW 264.7 cells cultured in normal and high 
glucose conditions in the absence and presence of stimulation  
At the end of the real-time NO measurements, the cell viability was assessed using a live 
dead assay as previously described. Overall the cells maintained good viability in all 
treatment groups. Normal glucose conditions with stimulation had a lower cell viability 
compared to normal glucose without stimulation and high glucose without and with 












4.2.4  The total real time-NO released compared to the nitrite accumulated 
in the media  
The real-time NO detected was integrated to obtain the total NO released and it was 
compared to the nitrite detected in the cell culture media (Figure 4-2). The total NO 
released in normal glucose conditions with stimulation was significantly higher compared 
to the nitrite that was collected in the culture media (161.80±29.05 vs 58±14.30 nmol/106 
cells n=3, p=0.005). High glucose followed a similar trend, the total real-time NO measured 
was higher compared to the nitrite although not statistically different (46.26±12.90 vs 
36.05±10.72 nmol/106 cells). Interestingly, for the cells cultured in normal glucose 
conditions, the total real-time NO analyzed was significantly higher than total real-time 
NO measured in high glucose conditions when stimulated (161.80±29.05 vs 46.26±12.90 
nmol/106cells n=3, p=0.00325). The nitrite measured was not statistically different in 
normal and high glucose conditions with stimulation.  
 
Figure 4-3 The cell viability detected by calcein AM and ethidium 
bromide for RAW 264.7 cultured in normal (NG) and high (HG) 
glucose media in the absence (-) and presence (+) of stimulation  
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4.2.5 Western blot analysis for iNOS protein levels in macrophages RAW 
264.7 cultured in normal and high glucose conditions  
RAW 264.7 cells seeded at the same cell density, were cultured in normal and high glucose 
conditions. At confluency, the cells were stimulated with 1ug/ml of LPS for 24 hours. The 
iNOS protein levels in the cells were analyzed using western blot. The results showed that 
the iNOS protein was not detected in the cells cultured in normal and high glucose in the 
absence of stimulation while the iNOS protein was upregulated in both normal and high 
glucose when the cells were stimulated (Figure 4-4) with the highest levels in macrophages 













Diabetic foot ulcers remain stalled in the inflammatory stage of wound healing and it’s 
suggested that the macrophages present in the wound retain their proinflammatory 
characteristics making it impossible for the wound to proceed to resolution. Nitric oxide is 
one of the key mediators produced by macrophages when faced with a hostile environment. 
Our lab has previously reported real-time NO levels from macrophage cells (RAW 264.7) 
cultured in high glucose conditions with stimulation by the inflammatory mediators LPS 
and IFN-ϒ[152]. Herein, we determined the real-time NO levels produced in RAW 264.7 
cultured in normal and high glucose conditions with and without stimulation by the 
bacterial product LPS (1 µg/ml). In the absence of stimulation, NO was barely detectable 
in the cells cultured in normal and high glucose media (Figure B-1). When the cells were 
stimulated by LPS, the real-time NO in normal glucose conditions was significantly higher 
compared to high glucose conditions (162± vs 46.25±1.29 nmols/106 cells). The results 
 
Figure 4-3. Western blot analysis for the detection of iNOS protein in 
normal (NG) and high glucose (HG) in the absence (-) and presence (+) of 
stimulation  
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presented in this chapter showed consistency with previous work under high glucose 
conditions[152]. Although slightly higher NO was detected in our study, it was still in the 
same order of magnitude (46.25±1.29 vs 35.37±2.90 nmol/106cells). Our work reports the 
first ever assessment of real-time NO produced from macrophage cells cultured in normal 
glucose conditions. There has been a lot of controversy in the literature in regards to the 
levels of NO in diabetic conditions (Table 2) and a similar trend is observed for 
macrophages cultured in normal and high glucose conditions. Tseng et al [216] showed 
that high glucose inhibited nitrite production and iNOS expression from macrophages 
while other studies show that the nitrite and iNOS protein levels  are elevated in RAW 
264.7 cultured in high glucose states[132, 217-220]. The evidence presented in these 
studies supports the results obtained by the authors. However, to base these findings purely 
on the metabolites of NO is not an accurate assessment. Nitric oxide reacts with a large 
number of oxidative molecules such as oxygen, transition metal ions, thiols to form other 
compounds, some of which metabolize to produce the same biproducts (nitrate and nitrite) 
as NO [203]. Moreover, depending on the surrounding environment, the NOS enzymes can 
also uncouple from its native NO metabolic pathway to generate the reactive oxygen 
species superoxide[96]. It is therefore critical to compare the actual levels of NO that the 
cells experience to the molecular pathways, protein levels and even culture environment 
that might affect the NO release or availability. The iNOS levels in our study strongly 
correlated with the real-time levels of NO observed in both treatment groups in the 
presence and absence of stimulation (Figure 4-2 and 4-4) with higher levels in normal 
glucose compared to high glucose conditions with stimulation (23151.96 vs 7975.66, n=3 
p=0.02). Miao et al[35] showed reduced iNOS expression and levels in macrophages 
isolated from the wounds from diabetic mouse. The same group also observed increased 
arginase expression in the macrophages present in the wound suggesting a greater 
population of alternatively activated or altered macrophage function in the diabetic wound. 
Other researchers have reported iNOS deficiency from genetically diabetic mice. 
Furthermore, the administration of NOS inhibitors has also been shown to delay 
reepithelialization and collagen formation[221]. The nitrite that was accumulated in the 
culture media was compared in both treatment groups and it was found to be slightly higher 
in normal glucose compared to high glucose with stimulation but not statistically different. 
The total real-time NO was significantly higher in normal glucose compared to the nitrite 
inferred in the cell culture media of the same treatment group while the nitrite and total NO 
in high glucose conditions was not significantly different (Figure 4-2). Macrophages 
produce both nitric oxide and superoxide when activated as part of the cell immune 
response[32]. Nitric oxide has a very strong affinity for superoxide and the reaction 
between the two species produces the more toxic compound peroxynitrite[58, 115]. 
Depending on the pH, peroxynitrite is oxidized to nitrite or nitrate[129]. In the presence of 
antioxidant molecules, the formation of this compound is modulated by scavengers of 
superoxide and nitric oxide [96]. High glucose levels alter the redox environment of the 
cells through various mechanisms[222]. One is through superoxide generation from the 
mitochondria which can activate the polyol pathway, increase consumption of NADPH a 
key cofactor required for NO synthesis and the activity of antioxidant molecules. The low 
NO levels in high glucose compared to normal glucose cell culture conditions that could 
be explained by this mechanism. The results strongly suggest a possible increase in 
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nitrosative stress for cells cultured under high glucose conditions. He and Frost[153] have 
shown that the generation of the reactive oxygen species such as superoxide greatly reduces 
the real-time NO levels produced from known NO donors and a similar mechanism might 
be observed in the cells.  In addition, chronic wounds of patients have been found to have 
high levels of uncontrolled ROS and RNS with an insufficient antioxidant response[203]. 
consequently, the indirect effects of NO are observed instead of its biological role.  
4.4 Conclusion 
The macrophage cell line RAW 264.7 is widely used as a positive control for NO 
production and iNOS expression in tissue and cell culture. Moreover, previous work also 
validated the temporal and spatial NO released from these cells cultured in high glucose 
conditions. Therefore, it seemed fitting to use these cells to confirm the results obtained 
from normal and wound fibroblasts cultured in similar conditions. The work presented here 
proves that nitric oxide is significantly suppressed in cells cultured in high glucose 
conditions and that the nitrite levels do not correlate with the actual NO levels that cells 
experience in normal and high glucose cell culture conditions.  The quantitative analysis 
of continuous real-time NO measurements is of utmost importance when understanding the 
role of NO especially in chronic pathological states and consequently can be used to 
develop treatments that will not only deliver the adequate dose of NO but also address the 
problem of increased oxidative and nitrosative stress, therefore increasing the 
bioavailability of NO in the wound.  
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5 CONCLUSION AND FUTURE WORK ON THE 
RELEVANCE OF REAL-TIME NO MEASUREMENTS  
Diabetes Mellitus remains one of the most challenging and complex pathologies of the 21st 
century and individuals affected with DM are always at risk for the development of 
complications such as DFU.  The risks of amputations and death are significantly higher in 
patients with DFU compared to patients without DFU.  These wounds take a very long 
time to heal because of the underlying metabolic condition of the patient as well as 
persistent infections.  Uncontrolled high glucose levels are characteristic for diabetic 
patients who develop DFU and downstream it triggers several metabolic pathways that 
interfere with the homeostatic environment that is necessary for the wound to heal. Nitric 
oxide is essential in the wound healing process. It is produced by cells that are actively 
present in the wound and is known to be involved in all the stages of wound healing. The 
effects of NO are like a double aged sword.  At low concentrations it modulates blood flow, 
angiogenesis, cell proliferation, migration and activates various signaling pathways. While 
at high concentrations it acts as a microbial agent to fight off infections in the wound. The 
levels of NO need to be precisely controlled and this achieved by scavengers and 
antioxidant systems under physiological conditions. Additionally, the timing of delivery is 
of extreme importance in achieving normal physiological functioning.  In diabetes, the high 
levels of glucose interfere with the metabolism of NO through a number of mechanisms; 
increased reactive oxygen species, reduced antioxidant levels, reduced co factors (NADPH, 
BH4). The result is reduced bioavailability of NO and ultimately NO function. The 
literature is vast on the effect of NO in the diabetic state however, the results reported are 
contradictory. The role of NO is clearly defined in physiological conditions and even in 
acute pathological states, the reported NO function is fairly consistent[190, 191, 223]. 
However, in regards to clinical application for chronic conditions such as DFU it still 
remains a challenge. Nitric oxide in the wound needs to maintain an extremely delicate 
balance when transitioning into different phases of the wound and this is achieved by a 
complex cascade of events involving cross talk between the cells and the surrounding 
matrix environment that act together to repair and restore the skin tissue barrier. Each of 
these events require different doses/durations of NO. Nitric oxide is very reactive and short 
lived. Understandably that makes it very difficult to measure and consequently the majority 
of studies in the literature rely on its oxidized products (nitrate and nitrite) to predict the 
NO function. This greatly under or over estimates the levels of NO that are actually needed 
because it does not give any information on the dynamic change of NO in specific 
conditions and how the NO levels change overtime. In addition, because of its reactivity 
NO generates reactive nitrogen species especially in conditions of oxidative stress as is the 
case of DFU.  These RNS can also metabolize to produce nitrite/nitrate creating a 
confounding effect/misinterpretation of NO function. Its therefore why we emphasize the 
need to compare the actual levels of NO that cells produce and to see how well they 
correlate with the nitrite/nitrate levels observed so as to determine if the effect observed is 
primarily due to NO or other factors that interfere with its bioavailability and then proceed 
accordingly.  The work presented in this dissertation assessed the real-time NO levels and 
nitrite produced from cells that are at the front line of the wound healing process under 
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normal and high glucose conditions. In Chapter two, the NO produced from normal human 
adult fibroblast cells was analyzed for normal and high glucose cell culture conditions in 
the absence and presence of stimulation. The NO levels were found to be higher in normal 
glucose compared to high glucose conditions when the cells were stimulated (8.42±1.16 
and 3.26±0.79nmol/105 cells). The nitrite levels correlated to the real-time NO levels for 
the cells in normal glucose conditions with and without stimulation. However, in high 
glucose conditions, the NO levels were not statistically different in the absence and 
presence of stimulation. The nitrite levels appeared higher but did not reach statistical 
significance in high glucose with stimulation compared to cells without stimulation. The 
iNOS protein was upregulated in all treatment groups but not statistically different. Further 
studies would need to be performed to determine the mechanism involved in NO synthesis 
in fibroblast cells.  After determining the NO levels expected in normal fibroblast cells, we 
adopted the same methodology to determine the NO produced from human adult wound 
fibroblasts isolated from a chronic non-healing wound (1 year and 8 months). The NO 
produced was slightly increased in normal glucose cells (4.08±3.38nmol/105) and yet 
suppressed in high glucose conditions and the NO profile was also markedly different 
compared to normal fibroblast cells. The nitrite/nitrate present in the wound bed was also 
analyzed and found to be significantly higher (micromolar compared to nanomolar range) 
compared to the NO levels produced from cells. The data suggests that there might be other 
cells responsible for the nitrite/nitrate levels observed or other factors present in the wound 
bed that interferes with NO function in the wound. The work from this chapter is part of 
an ongoing clinical study to determine how the NO levels differ in diabetic and non-
diabetic patients with chronic wounds. The data from chapter 4 looks at the NO produced 
from the macrophage cell line RAW 264.7 which has been validated in previous studies 
and was used to confirm NO and nitrite measurements obtained from normal and wound 
fibroblasts cultured in normal and high glucose conditions. There was absence of NO 
detected from cells cultured in normal and high glucose in the absence of stimulation. 
When stimulated we observed a similar trend with normal glucose showing significantly 
higher levels of NO compared to cells cultured in high glucose conditions (162± vs 
46.25±1.29 nmols/106 cells). There was no significant difference of nitrite levels in normal 
and high glucose with stimulation. The levels of the iNOS enzyme correlated with the real-
time NO levels but not the nitrite. While the molecular pathways through which NO 
availability is altered in diabetic conditions deserves further investigation than we can offer 
in this dissertation, the conclusion can be drawn that in addition to analyzing NO 
metabolites and NOS protein expression/levels, it is also fundamental to assess the 
temporal and spatial aspects of NO in real-time to clearly and accurately define the NO 
function in DFU. In the long term, it will facilitate engineering of precisely controlled NO 
treatments that can model the physiological NO symphony in wound healing and repair the 
damaged skin tissue.  
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5.1  Future perspectives 
We are at a precipice where the current research methodologies and treatment plans are 
mainly focused on either the positive or detrimental effects of NO and yet undermine the 
need for nitroso redox balance when treating chronic disease states. The use of real-time 
NO measurements addresses this limitation by monitoring the precise moment when NO 
affects different cell functions in a given experimental plan and then applying this 
knowledge to determine the causal factors or modify the treatment according to the changes 
observed.  
5.1.1 The use of localized NO delivery systems to control the effect of NO 
 Now that we know the NO levels produced from normal wound fibroblasts and 
macrophages cells. The challenge at hand is to determine whether we can incorporate the 
NO levels measured in the cells into smart NO release wound dressings that can locally 
deliver the correct doses of NO required for each cell population in a given sight of the 
wound without altering the surrounding environment.  Previously, an NO releasing 
polymer system that incorporates an S-nitrosothiol compound (S-nitroso acetyl 
penicillamine dimethyl siloxane (SNAP-PDMS)) was engineered in our lab that can be 
finely tuned to deliver controlled doses of NO by photoinitiation[224]. A gradient target of 
this polymer with varying concentrations of NO was prepared and applied to cells cultured 
in the upper chamber of the CellNO trap device to deliver NO to those cells (Figure 5-1A). 
The advantage of this system is that it allows us to deliver only NO to the cells so that when 
compared to the real-time NO or nitrite accumulation, the effect observed will be specific 
to either the dose of NO delivered or its bioavailability. Moreover, it can be modified to 
simultaneously track the changes in real-time. In our preliminary study we used this 
gradient as a localized NO treatment to assess the cell viability in the wound fibroblast 
cells used in chapter 3. The data showed that the viability of the cells exposed to the highest 
levels of NO was significantly reduced compared to cells exposed to lower doses of NO. 
In the same culture chamber an area of the cells was not exposed to the NO gradient target 
and these cells maintained over 95% cell viability (Figure 5-1B). The results clearly 
indicated that we can adopt this model to treat the cells with varying concentrations of NO 
that could have the potential to direct the migration and proliferation of cells from the 

















5.1.2  Quantitative monitoring of NO exposed to vascular smooth muscle 
cell cultures for applications in cardiovascular calcification  
Another application of the significance of real-time NO measurements is to determine the 
role of NO in cardiovascular calcification which has become a growing burden in 
westernized countries.  Calcification has severe clinical consequences in diseases such as 
calcific aortic valve disease, atherosclerosis, diabetes and chronic kidney disease [225, 
226]. In a meta-analytical study based on the presence or absence of calcification, the risk 
of any cardiovascular event, stroke and mortality in patients with heart disease, renal 
insufficiency and diabetes mellitus increased 3-4-fold in the presence of calcification after 
a 10 year follow up. The various treatment strategies that have been adopted to reduce the 
global burden of cardiovascular diseases do not address the problem of ectopic 
calcification. Nitric oxide has been proposed as a pharmaceutical option to halt the progress 
of ectopic calcification[227]. However, the effects of NO reported in the literature are 
controversial. Kanno et al [228] demonstrated that NO has an inhibitory role on vascular 
calcification by down regulating TGF beta signaling. In another study, the NO donor 
DETANO and valve endothelial cells had the same inhibitory effect on the calcification of 
a valve interstitial cell culture[229]. However, Alsabeelah [230] showed that NO 
aggravates vascular calcification through overexpression of iNOS enzyme. The drawback 
of all these studies is that they used soluble NO donors and recent work has shown the 
limitations of relying on the half-life of NO donors to investigate the biological role of 
NO[153]. In addition, the studies lacked real time measurements on the actual level of NO 
that cells experience at any given time in culture. The goal is to understand the role of NO 
in cardiovascular calcification by using the CellNO trap measuring device that will 
determine the actual level of NO that vascular smooth muscle cells are exposed to.  
 
Figure 5-1 The treatment of wound fibroblasts with NO polymer gradient target. 
Green and red represents live and dead cells respectively. Blue represents the 
cell nuclei. The arrow represents the boundary between cells exposed and not 
exposed to the NO treatment.   
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Primary vascular smooth muscle cells were isolated from the thoracic aorta of a rat. 
Immunofluorescent staining of the cell monolayers confirmed that the cell culture was 
mainly composed of smooth muscle cells by the presence of smooth muscle α actin in the 










The method from Kanno et al[228] was adopted to show that NO inhibits cardiovascular 
calcification when the cells are treated with 10µM of DETANO solution. The results 
showed that cell cultures in complete growth medium in the absence and presence of NO 
showed no signs of calcification. While the cells grown in osteogenic medium alone 
showed early signs of calcification. The cells cultured in osteogenic medium that contained 











Figure 5-2 The characterization of primary smooth muscle cells. Green and blue 














To determine the precise NO surface flux that the cells experience, we used the CellNO 
trap device that was previously developed [152, 231]. Cells were taken from passage 3-5 
and seeded at a density of 2.1×105 cells per well. At confluency, the medium was changed 
and 10µM DETANO solution was added. The NO release was recorded for approximately 
22 hours and cell viability in the device was confirmed by a live/dead assay using calcein 
acetoxymethyl ester (calcein AM) and ethidium bromide dye. The NO release profile of 
the NO donor alone in the device was recorded as well as the cells in the absence of the 
NO donor. Nitric oxide released in the cell culture increased gradually reaching a peak of 
approximately 0.05 picomoles /sec·cm2 and then decreased for a duration of 14 hours and 
remained constant after 20 hours. The NO release profile of the NO donor in the absence 
of cells followed the same trend but the level of NO recorded was lower compared to the 
NO release in the presence of the cells. Interestingly, the cell culture in the absence of the 
NO donor produced NO but in a much smaller quantity, reaching a peak of 0.01 
picomoles/sec·cm2 (Figure 5-4).  In previous studies, excess NO produced in vitro cell 
culture was assumed to be responsible for the adverse effects experienced by the cells due 
to the reaction of NO with reactive oxygen species[232, 233]. These data show how the 





Figure 5-3 Alizarin red staining of primary rat aortic smooth muscle cells in 
culture for 14 days in (A) complete growth medium (control), (B) osteogenic 
medium, (C) complete growth medium and 10 µM DETANO, and (D) osteogenic 













The ability to monitor this change in real time without altering the cell culture conditions 
would possibly explain the difference in observed effects of NO in calcification. This is 
the first study that has been able to achieve real time data on the actual level of NO that 
primary vascular smooth muscle cells require to inhibit matrix mineralization. Further 
investigation would involve assessing if the NO levels change in cells cultured in a 
calcifying media in the absence and presence of the NO donor. In addition, iNOS protein 
expression and the nitrite accumulation in the cell culture media needs to be analyzed and 
compared to the real time NO levels measured. It is highly possible that the results reported 
in the studies are consistent with the treatment delivered. However, the dose, duration and 
when in the cell cycle that NO is delivered maybe a key player to distinguish the observed 
effects of NO. The ability to determine this would require a highly controlled nitric oxide 
delivery system that can be modulated on demand. The SNAP-PDMS gradient strip with 
varying concentrations of the NO donor allows us to study dose effect simultaneously in 
the same cell culture to accurately determine the critical point when NO changes from an 
inhibitory to an aggravating effect on calcification. Real-time NO measurements will 
provide the armamentarium needed for custom designed drug delivery systems that can be 
applied to engineered constructs as well as pharmaceutical treatments to halt or slow down 





Figure 5-4  The real-time NO detected in primary smooth muscle cells cultured in 
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A Supplementary figures from Chapter 3 
A.1 Western blot analysis  
 
 
Figure A-1.  Western blot analysis for eNOS protein in normal (NG and HG) and wound 
fibroblasts cultured in normal (WN) and high glucose (WH)in the absence (-) and presence 
(+) of stimulation. RAW 264.7 and human endothelial cells were used as positive controls 
for iNOS and eNOS respectively. MOVAS cell line was used as a negative control for 









Figure A-2.  Western blot analysis to determine NF-κβ protein in wound fibroblasts 







A.2 Supplementary figures for nitrate and nitrite 
measurements  
 















Figure A-4 Maximum sensitivity for the nitrite/nitrate measurements  
85 
B Copyright documentation 
The document presented below shows that I obtained the rights to use the material 
presented in chapter 2 
 
